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STRUCTURE AND ENERGETICS OF RNA - PROTEIN INTERACTIONS FOR
HIV RREIIB TARGETING ZINC FINGER PROTEINS
by
SUBRATA H. MISHRA
Under the Direction of Dr. Markus W. Germann
ABSTRACT
RNA - protein interactions constitute a vital part of numerous biochemical
processes. In the HIV life cycle, the interaction of the viral protein Rev and the
Rev Responsive Element (RRE), a part of unspliced HIV RNA, is crucial for the
propagation of infectious virions. Intervention of this interaction disrupts the viral
life cycle.
Rev - RRE interaction initially occurs at a high affinity binding site localized
to a relatively small stem loop structure called RREIIB. This binding event has
been well characterized by a variety of biochemical, enzymatic and structural
studies. Our collaborators have previously demonstrated the efficacy of zinc
finger proteins, generated by phage display, in the specific targeting of RREIIB.
We have shown that the binding of these zinc finger proteins is restricted to the
bulge in stem loop IIB that Rev also targets. Currently these proteins bind
RREIIB with dissociation constants in the nanomolar range. We have employed a
wide assortment of biophysical techniques such as gel shift assays, circular
dichroism, isothermal titration calorimetry and NMR structural studies to further

investigate this interaction. Several mutants of the zinc finger proteins and the
RNA were also studied to delineate the parts of the protein secondary structure
as well as the role of specific side chains in this interaction. We have generated a
solution structure of the RREIIBTR RNA bound zinc finger protein, ZNF29G29R,
which displayed the highest affinity to this RNA. This has allowed us to shed
further light on the molecular basis of this RNA - protein interaction and provides
input for further refinement in our structure guided phage display.

INDEX WORDS: HIV, Rev Responsive Element, RNA, protein structure,
isothermal titration calorimetry, RNA protein interactions, zinc finger protein,
NMR structure, molecular recognition.
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CHAPTER 1 Overview
AIDS and HIV
Acquired immune deficiency syndrome (AIDS) is a fatal condition caused
by HIV (Human Immunodefficiency Virus) infection in its late stages, which
leaves the human body defenseless to opportunistic infections. Infected patients
are also at an increased risk of contracting several malignant cancers due to a
decimated immune system. Transmission of the virus occurs through exchange
of HIV infected bodily fluids such as blood, semen, vaginal fluid, preseminal fluid,
and breast milk (1).
The current global estimate (2007) for people living with HIV/AIDS stands
at a frightful 33.2 million while this global epidemic has already claimed 21 million
lives worldwide since 1981 (2). Currently there is no known cure, but
antiretroviral therapy combined with clinical care has been moderately effective in
increasing the life expectancy of infected patients. Efforts in combating this
epidemic are currently ongoing in worldwide research facilities with the objective
of disrupting the HIV replication cycle.

HIV replication cycle
The HIV virus belongs to the lentivirus genus and Retroviridae family that
also include retroviruses such as the Simian Immunodeficiency Virus (SIV),
Murine Luekemia Virus (MLV), Bovine Leukemia Virus, Human T-cell Leukemia
virus type 1 (HTLV-1) amongst others. Retroviruses carry with them a positive
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Figure 1.1 The HIV replication cycle (http://www.accessexcellence.org/AB/GG/retro_life.html).

single strand of RNA and reverse transcriptase to transcribe proviral DNA (1).
HIV-1 virions bind specifically to cells expressing CD4 and thus infect a
variety of immune cells such as CD4+ T cells, macrophages, and microglial cells.
The life cycle is shown in Figure 1.1. Viral entry occurs by interaction between
the viral envelope glycoprotein SU (gp120) and and the amino terminal domain of
the cell surface protein CD4 (3, 4). This fusion between the viral particle and the
cell also requires several chemokine receptors CXCR4 and CCR5 (5-7). Upon
membrane fusion and entry, reverse transcriptase (RT) transcribes viral DNA in
the cytosol (8). This is followed by the nuclear import as part of a preintegration
complex which includes integrase (IN), matrix protein (MA), reverse transcriptase
(RT), other viral accessory protein (Vpr), which aid in connecting this
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preintegration complex to the cellular nuclear import machinery. After nuclear
localization, IN catalyzes the integration to the host genome (9).
The HIV pre-mRNA that is transcribed from this proviral DNA contains
numerous splicing signals. In the early phase of the HIV life cycle, mostly 2 kb
mRNA transcripts are generated which are translated to the regulatory proteins:
Tat, Nef and Rev (10-12). Tat binds to the nascent RNA transcript (TAR RNA)
and with the aid of host cell proteins cyclin T and CDK9 stimulates transcription
elongation (13, 14). However, for HIV to produce its complete range of structural,
enzymatic and accessory proteins, it needs the unspliced ~9 kb and singly
spliced ~4 kb transcripts. In addition, it needs the unspliced transcipt for
assembly into the progeny virus particle. In order to do this, the translocation of
the intact unspliced and singly spliced transcripts to the cytoplasm has to be
carried out before complete splicing or degradation in the nucleus. This crucial
nuclear export is facilitated by the regulatory protein Rev which binds to the Rev
Responsive Element (RRE), a 234 nucleotide, untranslated RNA structure in the
env gene, with the help of host cell nuclear export machinery. The Rev-RNA
interaction is thus critical in the shift from production and cytoplasmic appearance
of fully spliced RNA to singly spliced and unspliced RNA for translation (15, 16).
The unspliced RNA transcript is translated into Gag and Gag-Pol proteins,
while the singly spliced transcripts encode Env, Vpu, Vif, Vpr and protease
proteins. The Env polyprotein (gp160) is synthesized in the endoplasmic
reticulum (ER) and trimerizes and undergoes extensive glycosylation to form the
transmembrane glycoprotein complex (TM-SU) (17). This complex is then
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transported to the cell membrane for viral assembly while at the same time
degradation of CD4, also produced in the ER, by Vpu is carried out to remove
any interference in the formation of the TM-SU complex. Concomitantly, cell
surface CD4 is downregulated by endosomal degradation by Nef, thus avoiding
immune response (18, 19).
The Gag polyprotein interacts with the TM-SU, while numerous copies of
Gag encaplsulate 2 copies of the viral genome. The polyprotein is cleaved by
protease to produce independent enzymes and structural proteins which
rearrange during a process called maturation forming the infectious viral particle
(8, 20). The budding off of the virus to infect other cells perpetrates the
progression to AIDS and decimated immune systems.

Nuclear export of unspliced HIV mRNA
The HIV pre-mRNA contains numerous splicing signals that by alternative
splicing result in the production of more than 30 different mRNA transcripts in the
early phase of the life cycle. This complete splicing of the pre-mRNA by the host
splicesosome complex results in only 2 kb RNA transcripts that encode the
regulatory protein Tat, Nev and Rev. In order for the lifecycle to shift to the late
phase of the lifecycle, HIV requires the translocation of its pre-mRNA out of the
nucleus before complete splicing. The Rev – RRE interaction serves this purpose
and facilitates the appearance of singly and unspliced (~ 9 kb and ~ 4 kb)
transcripts in the cytoplasm by diverting sufficient amounts of the same away
from the host nuclear splicing machinery (15). This transition from fully spliced to
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unspliced and singly spliced mRNA occurs only after critical concentrations of
Rev are reached in the cell (21). The Rev – RRE interaction thus forms an
important target for drug design and its efficient prevention could severely
hamper infectious virion production.
The nuclear export of HIV mRNA by Rev is displayed in Figure 1.2. After
initial binding of Rev to a specific region on RRE, a relatively small stem loop
structure called RREIIB, oligomerisation of up to a total of 8 Rev molecules
transpires through RNA-protein contacts (16, 22). This forms the nuclear export
signal and utilizes the cellular nuclear shuttling protein exportin-1 (XPO) and
nuclear export factor Ran guanosine triphosphate to translocate to the
cytoplasm. In the cytoplasm, GTP is hydrolyzed to GDP and the complex
dissociates. This releases the nascent unspliced mRNA for translation while Rev
which also contains a nuclear localization signal (NLS) at its N terminal shuttles
itself back to the nucleus for the next round of HIV mRNA export (16).
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Cytoplasm
Nucleus

Figure 1.2 Involvement of the host machinery in the nuclear export of unspliced and singly
spliced mRNA to the cytoplasm (15).

RRE – Rev interaction
The Rev Responsive Element (Figure 1.3) is a 234-nucleotide
untranslated region located in the Env gene. Initial binding of Rev is localized to a
35-nucleotide region called stem loop IIB. This is followed by oligomerizaton of
up to 7 more Rev molecules to form the nuclear export signal.
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Figure 1.3. Rev Responsive Element RNA.
(Left top) Sequence and secondary structural prediction of the 234 nucleotide Rev Responsive
element RNA with the high affinity stem loop IIB boxed (24).
(Left bottom) Diagramatic representation of the RRE attached to unspliced and singly spliced viral
RNA
(Middle) Stem loop IIB (RREIIB) used for biochemical studies. The phosphates critical to RREIIB
interaction determined by ethylation interference experiments have been marked by “•”. The
circled RNA bases are critical to Rev binding from chemical modification interference and in vitro
selection data (25, 26, 27). The red-boxed region demarcates the position of the new purine –
purine base pairs (23)
(Right) RREIIB is truncated to make it amenable to NMR studies (RREIIBTR) while still retaining
affinity for the Rev peptide (23)

The significance of the Rev–RREIIB interaction is underscored by studies
that have demonstrated that Rev is able to transport even nonviral nucleolar
RNAs containing the RREIIB stem loop IIB across the nuclear envelope (28).
Several studies have previously characterized this RNA – protein
interaction using a variety of biochemical, enzymatic, mutational and structural
techniques (25, 26, 27). These studies have located the regions and elements of
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stem loop IIB for Rev binding. NMR structural studies have utilized a RREIIB
analog RREIIBTR and the Rev peptide, a 17 amino acid arginine rich motif
(ARM) important to this binding event, to demonstrate that binding occurs in the
major groove of the RNA (29). Battiste et al. have shown previously by NMR of
the RNA imino protons that the Rev peptide–RREIIBTR interaction induces
formation of 2 new purine-purine base pairs (G-G and G-A) (23). These base
pairs are formed in the bulge (Figure 1.3) in the stem loop IIB that has also been
previously characterized by RNA mutational studies to be critical to Rev binding.

Strategies to inhibit RRE – Rev interaction
A comprehensive list of most targets in the HIV replication cycle and
biomolecular strategies involved in inhibiting the pathogenesis of the virus has
been well documented by Kjems et al. 2005 (30). In the case of inhibition of
RRE–Rev interaction some of these endeavors engage RNA based strategies
such as anti-sense RNA, RNA decoys, RNA aptamers, ribozymes, siRNA as well
as protein based strategies involving transdominant negative proteins (TNP),
chimeric / fusion proteins (nucleases) and intracellular antibodies.
While antisense RNA, siRNA can prevent either Rev – RRE interaction or
Rev protein expression by binding to RRE, ribozymes have been designed as
nucleases to cleave RRE specifically. Protein based strategies target the Nuclear
Export signal (NES) or Nuclear Localization signal (NLS) region on Rev by use of
TNP’s, intracellular antibodies whereas RRE RNA decoys and aptamers prevent
the initial high affinity binding of Rev to RRE stem loop IIB. Small molecules that
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interact with Rev, RRE or host cell factors have also been reported but had
significantly higher cytotoxicity and/or low specificity in comparison to their
biomolecular counterparts (37).

Design of RREIIB binding zinc finger proteins
The interference of the RREIIB-Rev interaction by designed peptides has
been attempted using numerous biocombinatorial methods (31-35). Our
collaborators have previously demonstrated high affinity RREIIB binding dual
zinc finger proteins, which had been evolved by phage display (33, 34). The ##"
scaffold of zinc finger protein has also been utilized to stabilize the "-helix of the
Rev peptide to bind stem loop IIB, and not surprisingly had affinity close to the
RREIIB-Rev peptide complex (35). In order to prevent the RREIIB-Rev
interaction, drugs or macromolecules capable of binding to the Rev localized
region on the stem loop IIB with affinities several fold higher than the original
binding

are

required.

The

Rev–RREIIB

dissociation

constant

(Kd)

is

approximately 300 nM (35). The dual zinc fingers generated by our collaborators
have dissociation constants under 100 nM (36). These zinc fingers were
generated by randomizing amino acids on the "- helical region of the 4th zinc
finger of Transcription factor IIIA by phage display. The TFIIIA is a multi-ZNF
protein where the 4th–7th zinc fingers bind RNA specifically. Hence their
scaffolds served as able RNA binding motifs that were tweaked by
biocombinatorial method such as phage display to specifically bind RREIIB.
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Experiments were also performed to illustrate the efficacy of in vivo binding of
RREIIB element by these zinc fingers (34).
It has also been previously demonstrated that in the 2-zinc finger construct
the N terminus zinc finger is acidic and the onus of binding is almost entirely on
the C terminal zinc finger (33, 36). As a result our further studies have focused
on this single zinc finger and its interactions with RREIIB. This single zinc finger
is a 29 amino acid protein named ZNF29. A C-terminal mutation of a glycine to
arginine, producing a 3-fold increase in affinity but with the same mode of binding
as ZNF29, resulted in the protein for our studies (ZNF29G29R).

Dissertation objectives
The objective of the studies described in this dissertation is to delineate
the binding interaction of ZNF29G29R to RREIIBTR through energetic and
structural viewpoints. To this effect we have used a combination of biophysical
methods involving gel shift assays, CD, Isothermal titration calorimetry and NMR.
Several mutations of ZNF29 as well as RREIIB analogues were used in the
above-mentioned techniques to dissect the driving forces behind this
macromolecular interaction. The protein mutants evaluated demonstrate
secondary structural elements as well as the import of specific amino acid side
chains in binding. These protein mutants were evaluated by gel shift assays to
get dissociation constants, isothermal titration calorimetry (ITC) to illustrate
energetics and by imino NMR to differentiate binding mode to RREIIBTR. The
energetics and imino NMR data were compared and contrasted to glean
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information about this interaction. RREIIB analogs were also studied by ITC
methods as well as imino NMR to shed light on the identity of the new peaks
produced by RREIIBTR - ZNF29G29R binding. Paramagnetic studies with Co2+
loaded zinc finger proteins were used to demonstrate localization and binding
orientation of ZNF29G29R to the bulge on stem loop IIB. Furthermore, a varierty
of NMR experiments were performed to calculate a solution structure of the zinc
finger bound to RREIIBTR RNA. Finally, the culmination of all these data to make
recommendations to further biocombinatorial approaches for refinement of this
interaction has been discussed.
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CHAPTER 2 Production and purification of zinc finger proteins
and RNA
Introduction
The biological activity of proteins, purified from bacterial sources, is
dependent on storage conditions that promote stability of their tertiary structures.
Therefore, methods to validate the original structural integrity of proteins, isolated
and stored as separate batches, ensure reproducibility of experimental results.
Also, in protein - RNA interactions, electrostatic interactions are expected to
make a significant contribution. Hence, it is imperative to estimate the amount of
salt in the protein solutions utilized. Establishing the stoichiometry of binding in
the protein - RNA complex necessitates accurate determination of their
concentrations, especially for ITC experiments. We have utilized NMR and UV visible spectroscopy to determine protein yields, folding, concentration and
amount of salt (sodium ions) in protein stock solutions. In addition, all protein and
RNA sequences used in our experiments, their purification protocols and their
assigned names are detailed in this chapter.

Protein production, purification and yields
Zinc finger proteins were produced as fusion proteins with an N-terminal
Thioredoxin (THX) and (His)6-tag. All zinc finger proteins used in subsequent
chapters are displayed with their amino acid sequences, assigned names and
yields (fusion protein and final purified protein) in Table 2.1. Except for
ZNF29H6A, ZNF29H6K, ZNF29N15A and ZNF29D16A, all other proteins had
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previously prepared bacterial strains (1). The plasmids for these 4 were
constructed by site directed mutagenesis with respective primers, mentioned in
Appendix A, on ZNF29 plasmid using Stratagene’s QuikChangeTM site-directed
mutagenesis kit (Stratagene, La Jolla, CA) and transformed into BL21De3
competent cells. Protein production and purification protocols have been carried
out as outlined in detail in Mishra et al., 2006 (2) until the penultimate step (size
exclusion chromatography on the 16/60 Superdex Column). The final purification
step has been outlined below.
All our zinc finger proteins have molecular weights in the range of ~ 3500 D
and pI’s above 10. This presented a challenge in obtaining high concentration
protein solutions with low concentrations of NaCl. Since our proteins are
positively charged, the choice of dextran-based desalting mediums, which do not
bind these proteins in the absence of salt, were limited. The use of
dialysis/ultrafiltration for removal of salt and/or buffer exchange was hampered by
the unavailability of dialysis membranes and ultrafiltration discs with desired
molecular weight cut-offs. Initially we tried buffer exchange after the size
exclusion (SEC) step, by ultrafiltration, using a 10 mL Millipore stirred cell with
500 D Millipore Amicon filter membranes. However, this resulted in significant
losses of protein. We have also tried a variety of purification protocols ranging
from acetone precipitation to reverse phase chromatography, with little success.
We finally found a desalting column from Pierce (5 mL D-Salt ExcelluloseTM) that
had a size exclusion limit of 5000 D and had low binding to our zinc finger
proteins. Henceforth, all zinc finger proteins were desalted on this D-Salt

Table 2.1 Zinc finger proteins and mutants.
Zinc Finger Protein Names

Amino Acid Sequence

ZNF29

MVYVCHFENCGRSFNDRRKLNRHKKIHTG

ZNF29G29R

MVYVCHFENCGRSFNDRRKLNRHKKIHTR

ZNF29H6A

MVYVCAFENCGRSFNDRRKLNRHKKIHTG

ZNF29H6K

MVYVCKFENCGRSFNDRRKLNRHKKIHTG

ZNF29R12A

MVYVCHFENCGASFNDRRKLNRHKKIHTG

ZNF29N15A

MVYVCHFENCGRSFADRRKLNRHKKIHTG

ZNF29D16A

MVYVCHFENCGRSFNARRKLNRHKKIHTG

ZNF29N21A

MVYVCHFENCGRSFNDRRKLARHKKIHTG

ZNF29N21Q

MVYVCHFENCGRSFNDRRKLQRHKKIHTG

ZNF28*

VYVCHFENCGRSFNDRRKLNRHKKIHTG

15

N labeled ZNF29

MVYVCHFENCGRSFNDRRKLNRHKKIHTG

15

N labeled ZNF29G29R

MVYVCHFENCGRSFNDRRKLNRHKKIHTR

15

N

13

C labeled ZNF29G29R

MVYVCHFENCGRSFNDRRKLNRHKKIHTR

Fusion Protein Yields
mg/L bacterial culture

Final Purification
Yields
mg/L bacterial
culture

226
245

21.2
28.4

247
175
137

18.4
14.6
10.8

204
240
216
230

16.5
14.9
18.8
17.6

120
150
187

13.2
14.6
16.5

* chemically synthesized
Zinc finger proteins and their amino acid sequences are displayed above. The fusion protein consisted of THX-His6 tag –
enterokinase cleavage site- zinc finger (N – C terminal). Fusion protein yields refer to protein concentrations before
enterokinase cleavage. Fusion protein concentrations were determined by UV spectroscopy while final protein
concentrations were determined by 1D NMR spectroscopy. The amino acid letter code marked in red indicates that protein to
be a mutant of the original zinc finger ZNF29 and the naming convention indicates the mutation and its position in the
sequence.

18

19
ExcelluloseTM column as described below.
The SEC fractions containing protein (amounting to roughly 20 mL in
volume) were degassed, frozen and lyophilized. The lyophilized fractions were
rehydrated in approximately 4 mL of 200 µM degassed !-mercaptoethanol. This
protein solution was loaded in 0.5 mL fractions onto the D-Salt ExcelluloseTM
column for each desalting run. The column was equilibrated with 200 µM
degassed !-mercaptoethanol solution before protein loading. Fractions were
collected by gravity flow by adding running buffer (200 µM degassed !mercaptoethanol) and checked by UV spectroscopy and SDS PAGE for
presence of protein. The protein was found to elute in the 2.5 – 4.75 mL range.
The 2.5 – 3.75 mL and 4 – 4.25 fractions were pooled from multiple runs and
stored separately as the main fraction and side fraction respectively for each
protein (Figure 2.3). Isotope labeled proteins were produced by the protocol
outlined in Marley et al., 2001 (3), and purified as mentioned above. The yields
for ZNF28 were low when produced bacterially and ZNF28 had to be chemically
synthesized and obtained from Genscript Corp. The molecular weight of all
proteins and their identities were confirmed by mass spectroscopy.
The concentrations of proteins (fusion and final products) were determined
by UV spectroscopy and 1D NMR. For UV spectroscopy, extinction coefficients
of 11400 M-1cm-1 and 1490 M-1cm-1 were used for the fusion protein and final
purified protein respectively. Furthermore, the final protein product concentration
was also determined by integration and comparison of the known phenylalanine
and histidine signature peaks from 1D NMR experiments to the integral of an
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internal standard (2,2-dimethyl-2-silapentane-5-sulfonate sodium salt, DSS). For
all experiments the concentration determined by NMR was used.

Protein folding
Zinc finger (ZNF) proteins are characterized by their !!" motif with 4 amino
acids (combinations of cysteines and histidines) co-ordinating a zinc ion in the
hydrophobic pocket between the !-sheet and the "-helix. ZNF’s are further
classified based on the combination and identity of Zn2+ co-ordinating amino
acids. Our ZNF’s have 2 cysteines and 2 histidines that co-ordinate zinc and
hence belong to the Cys2His2 family of ZNF’s. The properly folded zinc finger
results in diagnostic chemical shift changes for Phe14 4H as well as the His27
2H in the hydrophobic core for Cys2His2 ZNF’s. (Figure 2.1, A) (4). Folded ZNF
proteins also displayed well dispersed 1D NMR spectra in the aromatic region in
contrast to their unfolded counterparts (Figure 2.1 B).

His27, 2H
Phe14, 4H

Figure 2.1 Zinc finger
folding.
1
H-NMR spectra of 0.5 mM
ZNF29G29R protein in 10
mM sodium phosphate pH*
6.8, 2 mM !me, 200 µM
NaN3, 50 µM ZnSO4
acquired at 298 K. (A)
Folded form with the
arrows indicating the
‘‘signature’’ chemical shifts
of His27, 2H and Phe14,
4H (B) Unfolded form
obtained by addition of 5
mM EDTA.
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ZNF29

ZNF29H6A

ZNF29H6K

22

ZNF29R12A

ZNF29N15A

ZNF29D16A

23

ZNF29N21A

ZNF29N21Q

ZNF28

Figure 2.2 ZNF29 and mutants: protein folding.
Signature chemical shifts of folded zinc finger motif displayed by ZNF29 & mutants. Solution
conditions are the same as ZNF29G29R in Figure 2.1. All mutants except ZNF28 were
bacterially produced. ZNF28 was chemically synthesized, folded by an equivalent amount of
2+
TM
Zn and purified by D-Salt Excellulose column chromatography.
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The presence of these distinct resonance peaks in the 1D NMR sample of
our zinc finger proteins in D2O greatly facilitates monitoring of folded and
unfolded states of different batches of expressed protein. For structure
determination and RNA binding studies, it is essential that pure protein in a single
(active) conformation be present. Protein folding was checked for all ZNF
proteins, as mentioned above, before use in binding experiments (Figure 2.2).

Protein stability
Protein stability, as viewed from a folding viewpoint, was checked over
ranges of pH and temperature for ZNF29 and ZNF29G29R. Both proteins
exhibited stability in the temperature range 293 – 333 K and in the pH* range 5.6
– 8.0. More details have been provided in Mishra et al., 2006 (2). Protein
unfolding could be achieved in a 15 – 30 min time scale by addition of excess
EDTA. The time scale is important as it can be compared to the time required for
the protein to unfold when bound to RREIIBTR, under similar conditions of pH
and temperature (Chapter 3).

Salt concentration
23

Na is an NMR active nucleus. This has allowed us to estimate NaCl

concentrations in our protein solutions by 1D

23

Na NMR. We first acquired 1D

23

Na NMR spectra for independently prepared solutions of 50, 100 and 200 mM

NaCl in D2O. NaCl concentrations of protein solutions were then estimated by
determining the ratio of their respective

23

Na peak with the peaks of the
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previously mentioned solutions. The concentration noted down was an average
of the 3 ratios. This allowed us to prepare solutions for our protein RNA binding
experiments with reasonably accurate salt concentrations after considering the
already existing salt in purified protein stock solutions. We have also determined
the salt elution profile of the D-Salt ExcelluloseTM column by this method (Figure
2.3).

µ

TM

Figure 2.3 Protein and NaCl elution profile of D-Salt Excellulose column.
Protein (ZNF29G29R) concentrations were measured by UV spectroscopy (280 nm) while
23
NaCl concentrations were measured by Na NMR. The left y axis denotes protein
concentration in µM while the right y axis denotes NaCl concentrations in mM. Protein main
fraction consisted of eluted fractions from 2.5 – 3.75 mL while side fractions were from 3.75 –
4.25 mL.

Protein storage
All zinc finger proteins were stored as lyophilized aliquots of protein in 200
µM degassed !-mercaptoethanol solution at -80 °C.
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RREIIBTR and mutants
Structural studies of the RREIIB – Rev interaction by Battiste et al., 1994
(2) used a truncated version of the RNA, RREIIBTR (Figure 1.3, right). This RNA
was shown to be amenable to NMR studies while still retaining features of the
original RREIIB RNA that are crucial to Rev binding (5). We have used
RREIIBTR for all our studies. We have also used RREIIBTR with modifications
and further truncated forms for NMR imino experiments and ITC (Table 2.2).
All RNAs with 2’- bis(acetoxyethoxy)-methyl ether protection groups were
obtained from Dharmacon Research Inc., and were deprotected, purified and
desalted as explained in Mishra et al., 2006 (2). Purified RNA was checked on
15% denaturing polyacrylamide gels. Bands were visualized by UV shadowing.
RNA concentration was determined by UV spectroscopy at 85 °C using an
extinction coefficient of 357040 M-1cm-1 for RREIIBTR. The extinction coefficients
of RREIIBTR and the other RNAs in Table 2.2 were calculated from values of
individual nucleotides at 85 °C.
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Table 2.2 RREIIBTR variant sequences and modifications.

RNA
RREIIBTR

Sequence
g

ggu cug ggc gca gcg caa gcu gac ggu aca ggc c

RREIIBTR_12upper

cag cgc aag cug

RREIIBTR_12lower

ggu cgc aag gcc

RREIIBTR_16

ggu cug gca aca ggc c

RREIIBTR_G50_2AP

ggu cug ggc (2AP)ca gcg caa gcu

RREIIBTR_G70_2AP

ggu cug ggc gca gcg caa gcu gac (2AP)gu aca ggc c

RREIIBTR_G47_2AP

ggu cug (2AP)gc gca gcg

RREIIBTR_G48_71_2AP

ggu cug g(2AP)c gca gcg caa

RREIIBTR_U72_3MU

ggu cug ggc gca

gcg caa gcu gac gg(3MU) aca ggc c

RREIIBTR_C49U

ggu cug ggu gca

gcg caa gcu gac ggu aca ggc c

RREIIBTR_C69U

ggu cug ggc gca

gcg caa gcu gau ggu aca ggc c

RREIIBTR_32

gu

cug ggc

caa

gcu

gac

ggu

aca ggc c

gac ggu aca

ggc c

gcu gac g(2AP)u aca ggc c

gca gcg caa gcu gac ggu aca ggc

RREIIBTR is the original 34 nucleotide RNA. The other RNAs are truncated versions or
modifications or variant sequences of RREIIBTR. The suffix added to RREIIBTR name
represents the following:
12upper: 12 nucleotides long RNA from the upper stem of RREIIBTR
12lower: 12 nucleotides long RNA from the lower stem of RREIIBTR
16: 16 nucleotides long RNA from the lower stem of RREIIBTR + GCAA loop
G50_2AP: RREIIBTR with G50 replaced by a 2-aminopurine
G70_2AP: RREIIBTR with G70 replaced by a 2-aminopurine
G47_2AP: RREIIBTR with G47 replaced by a 2-aminopurine
G48_71_2AP: RREIIBTR with G48 and G71 replaced by 2-aminopurine
U72_3MU: RREIIBTR with N3 methylated U72
C49U: RREIIBTR with C49 replaced by U49
C69U: RREIIBTR with C69 replaced by U69
32: 32 nucleotide long RREIIBTR starting from G42
The numbering of the RREIIBTR sequence was from Battiste et al., 1995 (5)

Conclusion
The protein production and purification protocols used yield sufficient
amounts of pure protein. The monitoring of the protein fold and salt
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concentrations provided consistency in our experimental results.
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CHAPTER 3 Preliminary analysis of RREIIBTR - ZNF interactions
Introduction
In order to analyze ZNF - RNA interactions, we have conducted
preliminary studies to address secondary structural changes, binding localization
on the RREIIBTR, orientation of binding for the protein, stoichiometry and
specificity of binding. The various techniques mentioned in this chapter have
been used in the following manner to illustrate interactions between RREIIBTR
and zinc finger proteins.
1. Circular dichroism (CD) has been used to probe for any secondary structural
changes that biomolecules (RNA or protein) undergo following the binding event.
2. Imino proton peaks indicate base pairing in nucleic acids. Detection of new
peaks in the NMR imino proton spectra for the complex shows new base pairs
formed, whose identity can be determined by NOESY cross peaks to previously
identified unperturbed resonances in the free RNA. Additionally, chemical shift
perturbation of the RNA imino peaks serves as a handy tool to localize the
binding of the zinc finger proteins on the RNA.
3. In addition to determining the ZNF binding location on the RNA, it is also
important to evaluate binding orientation. The !!" motif of zinc finger proteins
gives them a cylinder-type geometry with the N-terminus and tip of the zinc finger
representing one end of the cylinder while the C-terminus represents the other.
We have substituted zinc in the ZNF with a paramagnetic metal ion with similar
metal coordination geometry viz. Co2+. The metal coordination in the ZNF is
situated closer to the C-terminus end of this “cylinder”. The broadening of specific
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peaks in the imino proton spectrum of RREIIBTR, bound to this cobalt substituted
ZNF, has allowed us to shed light on the binding orientation.
4. The changes in the ZNF protein backbone, on binding RREIIBTR, have been
addressed by comparing the free and bound 15N HSQC spectra.
All the above-mentioned experimental techniques have also confirmed the
stoichiometry and specificity of ZNFs binding to RREIIBTR.

Structural changes in RREIIBTR on ZNF binding: CD
CD spectra of biomolecules are used to analyze their secondary
structures. We have compared the CD spectra of the free and ZNF29G29R
bound RREIIBTR. Since the sensitivity of a CD signal is comparable to that of
absorbance, the RREIIB CD signal dominates that of the protein in the complex
CD spectrum.
All CD experiments were recorded at room temperature on a Jasco J-710
spectropolarimeter. The CD spectrum for the free ZNF29G29R was subtracted
from that of the complex.
The free RREIIBTR CD spectrum is that of a typical right-handed A-RNA
(1) (Figure 3.1) with a maximum near 260 nm, a minimum near 210 nm and 2
small negative peaks at 240 nm and between 290 and 300 nm. Upon addition of
ZNF29G29R at a 1:1 stoichiometry, we see an slight increase in the intensity of
the peaks at the above-mentioned wavelengths. These minor differences
between the free and ZNF bound RNA suggests minimal changes if any, in the
secondary structure of RREIIBTR, on ZNF binding. The marginal increase in
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CD [mdeg]

intensity might be a result of additional base pairing.

Wavelenghth [nm]
Figure 3.1 CD spectra of free RREIIBTR RNA (red) and ZNF29G29R complexed RNA (blue).
A 1:1 ZNF29G29R-RNA complex at a concentration of 10 µM in 10 mM sodium phosphate, 50
mM NaCl, pH 7.0, buffer at 298 K. Spectra (20 scans) were acquired in a 0.2 cm cuvette using a
scanning speed of 200 nm/min.

Imino NMR
Labile protons in nucleic acids viz. imino protons, are visible in an NMR
spectrum when their exchange with the solvent is slowed down, compared to the
NMR time scale. This reduced exchange with the solvent is generally evidence of
base pairing but could also indicate RNA–protein contacts in a complex or
removal of a solvent accessible base to a solvent excluded region. Additionally,
imino protons resonate further downfield than most other labile and non-labile
protons of a biomolecule, thus providing a lesser degree of overlap and more
amenable analysis.
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Free RREIIBTR
The assignments of the imino resonances in the free RNA were obtained
from previously published data (2) (Figure 3.2). All imino spectra henceforth had
the same experimental parameters as stated in the legend of Figure 3.2, unless
mentioned otherwise.
A

B

C
U43

D

Figure 3.2 Imino NMR of free
RREIIBTR.
A. Free RREIIBTR published
assignments (2) B. Sequence of
RREIIBTR (2) with regions
highlighted: upper stem , middle
stem , bulge , lower stem .
C. Complete assignment of all
RREIIBTR imino resonances. G41
and G55 were assigned from Figure
3.4. RNA sample conditions:
10 mM NaP buffer, pH 7.0, 100 mM
NaCl, 200 µM !me, 298 K. NMR
spectra was collected using 1-1 jump
and return pulse sequence (11).
D. NOESY imino region of the free
RREIIBTR with 150 ms mixing time
and 1.5 s relaxation delay. The
spectrum was collected using the
NOESY version of the 1-1 jump and
return pulse sequence. NOESY crosspeaks confirm assignments displayed
in part C.
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These assignments were also confirmed by the NOESY spectra shown in Figure
3.2 D and other truncated versions of RREIIBTR (Figure 3.4). The truncated
versions of RREIIBTR also allowed us to assign G41 and G55, which were not
published previously (2).
The assignments for the truncated versions of RREIIBTR were made by
monitoring the sequential broadening of peaks in the imino spectra with
increasing temperature. For example, a 12 base RNA oligonucleotide
representing the upper stem of RREIIBTR was subjected to a temperature range
of 283 – 303 K (Figure 3.3). The NMR imino spectrum has 5 resonances as
expected, 4 base pairs and the solvent inaccessible G55. We observe that with
increasing temperature, the peak at 12.66 ppm is the first to broaden followed by
resonances at 13.98, 13.06, 13.43 and 10.75 ppm in succession. Though there
are minor changes in chemical shift with increasing temperature, there
G53
U66

G64

is

66 67
G67

G55

53

5’

Figure 3.3 Upper stem of RREIIBTR.
(left) Imino spectra of 12 base RNA
oligonucleotide which represents the
upper
stem
of
RREIIBTR
at
temperatures 283, 293, 298, 303 K.
(upper right) Sequence of the above
mentioned RNA.
The numbering scheme is the same as
used by (2).
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adequate chemical shift dispersion to identify these peaks. Since the end of an
oligonucleotide is the first to lose base pairing at increased temperatures, the
resonance at 12.66 ppm is identified as G67. The other resonances were
identified as they successively broadened with increasing temperature (Figure
3.3). It should be noted that G53 posseses higher thermal stability due to
stacking and has been assigned accordingly.
We have used 2 truncated versions of RREIIBTR similarly (Figure 3.4),
representing different sections of the free RNA, to identify and confirm the
resonances presented in Figure 3.2.

77

A
43

41

B

C
67

53

Figure 3.4 Assignment of RREIIBTR from its truncated versions.
A. Imino spectrum of RNA representing the lower stem of RREIIBTR (G41–C44 and G76-C79)
with GCAA tetraloop. (RNA sequence on the right)
B. Imino spectrum of full length RREIIBTR along with its sequence (2)
C. Imino spectrum of upper stem (C51 –G67) with RNA sequence.

RREIIBTR – ZNF comex
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RREIIBTR – ZNF complex
A titration of ZNF29G29R into RREIIBTR monitored by imino NMR spectra
results in shifts of specific peaks and the appearance of new imino proton
resonances, while some resonances do not show any shift at all (Figure 3.5).
Both ZNF29 and ZNF29G29R had essentially superimposable imino spectra for
their respective complexes with RREIIBTR. The resonances of the complex are
broader than the free RNA, as would be expected due to the increased molecular
mass for the complex. Additionally, there were no differences in the protein: RNA
complex at 1:1 and 1.5:1 ratios (Figure 3.5). These observations indicate specific
binding of both zinc finger proteins to RREIIBTR at 1:1 stoichiometry.
The 1:1 protein RNA complex showed distinct changes in chemical shift for
U66 and U45. The NOESY spectra for the imino region identified only U45 due to
its NOE cross-peak to G76 (Figure 3.7, I). No chemical shift changes were
observed for imino protons near the upper stem (G53, G64) or near the 5’ – 3’
terminus of the lower stem (G42, U43, G76, G77) during the titration. This
precludes these regions (Figure 3.5) from being at the binding location, thus
restricting the zinc finger binding site to the same bulge region on the RNA that
the Rev peptide utilizes.
The imino spectrum of the complex displayed new peaks at 13.3, 12.6,
12.65, 12.26 and 11.85 ppm other than the chemical shift changes for U66 and
U45 (Figure 3.7, II). The peak at 12.84, which corresponds to G41 in the free
protein, also appears intensified. The NOESY spectra did not show any cross
peaks to these new peaks to aid in their identification. Also, unlike the NOESY
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U66

Figure 3.5 Titration of RREIIBTR with ZNF29G29R followed by NMR at 298 K.
Protein: RNA molar ratios 0:1, 0.5:1, 1:1, 1.5:1 were achieved by adding 20 µl aliquots of
ZNF29G29R (1 mM stock) to a 100 µM RNA sample. The change in the chemical shift of the
U66 resonance at 13.9 ppm is specific for RNA protein complex formation, have been indicated
by dotted lines. The base pairs with unaffected imino proton chemical shifts after formation of a
protein RNA complex are marked by gray boxes. Sequence of the RNA is displayed to the right
with gray boxed regions corresponding to those shown in the imino spectrum. Note: This data
has been published (13).

data for the RREIIBTR – Rev peptide complex (2), where a purine - purine base
pair (G48 – G71, 12.2, 12.5 ppm) is formed on binding, we see no such intense
cross peak that would indicate the same is occurring in the formation of our
complex. In fact, a comparison of the RREIIBTR complex with the Rev peptide
and that formed with our ZNF (ZNF29G29R) showed little similarity, except in the
downfield shift of U66 (Figure 3.6).
In order to confirm that all new peaks in the complex belonged to the RNA,
we have compared the

15

N coupled and decoupled 1D NMR imino spectra of a
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RREIIBTR (14N) – ZNF29G29R (15N labeled) complex. The

15

N coupled and

decoupled imino spectra are expected to show no differences if all peaks belong
to the RNA. However, we observe splittings of ~ 80- 90 Hz in the

15

N coupled

spectrum (Figure 3.7, II, A) at 13.3 and 12.26 ppm. This proves that these
resonances originate from the protein. Subsequently, we identified these
resonances to be His 23 # 2H and His 27 # 2H when we inspected the 10 -14
ppm region of a 1D 1H spectrum of the free ZNF in water (Figure 3.7, III). Thus
our complex has 3 visibly distinct new RNA imino peaks if we disregard the
possibility of any new peak under the G41 peak and in the 12 -12.4 ppm region
(Figure 3.7, II, B). The identity of these new RNA imino peaks has been
complicated by the paucity of NOESY data to known resonances.

A

B

Figure 3.6 Comparison of RREIIBTR imino complex spectra with Rev and ZNF29G29R.
A. Published imino spectra of RREIIBTR-Rev peptide complex (2). B. Imino spectra of
RREIIBTR-ZNF29G29R complex. Blue rhombuses indicate changes in chemical shift while
red rhombuses indicate new imino peaks.
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(I)

G42 - G77

G42-U43

U45 - G76

G46 - G77 U43 - G77

G76 - U43

G53 - G64

G64

(II)

G76
G42 G53

G46

U43
G77

U45

B

U66

A

(III)

His 27 #2 H

His 23 #2 H

Free Protein
ppm

Figure 3.7 Identification
of new imino region
resonances.
(I) NOESY spectrum of
RREIIBTR-ZNF29G29R
complex with assigned
cross-peaks.
(II A) Imino spectra of
14
RREIIBTR ( N) –
15
ZNF29G29R ( N labeled)
15
complex with N
decoupler turned off.
(II B) Imino spectra of
14
RREIIBTR( N) –
15
ZNF29G29R ( N labeled)
15
complex with N
decoupler turned on.
The red dotted lines are on
the split peaks and the
green dotted lines are the
decoupled peaks. Only
one of the split peaks is
visible in both cases.The
difference between the red
and the green lines is
approximately 45 Hz
indicating a full splitting of
~ 90 Hz. These peaks
belong to the protein and
are marked by a black
filled star while RNA peaks
are marked by black filled
circles). The carrier for the
15
decoupler ( N) was set at
120 ppm.
(III) 1D 1H spectra of free
ZNF29G29R in water in
the same buffer and
temperature conditions as
II above acquired by 1-1
jump and return pulse
sequence (11). The
identity of the peaks were
obtained from a 1D NOE
difference experiment for
the free protein.
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Since there are no major rearrangements in the RNA secondary structure
upon ZNF binding, as shown by CD, we hypothesized that the 2 new peaks (12.6
and 12.65 ppm) could originate from the base pairing of G50 - C69 and G70 C49. These base pairs are not formed in the free RNA, but they are formed in the
RREIIBTR-Rev complex (2). Additionally, it is possible that the broad peak at
11.85 ppm could originate from either stacking of the U72 base in the bulge or
interaction of the U72 imino group with the protein. We also do not know if new
peaks actually do arise under the G41 resonance or the overlapped region from
12 – 12.4 ppm. In order to address these hypotheses, we have designed a
number of RNA mutants and variants and monitored their NMR imino proton
spectra on ZNF binding (ZNF29G29R).
RNA variants were made by modifications in the bulge and the middle stem
by replacing guanine bases by 2 - aminopurine. This base replaces a hydrogen
for the 6-oxo moiety of G and thus does not have an imino proton. Hence, if any
of the new peaks belong to the modified position, they would be absent in the
modified RNA – ZNF complex spectrum. The RNA mutants were made by
replacing the cytosine bases in the middle stem (above the bulge) by uracils.
These RREIIBTR variants and mutants and their respective imino spectra on
ZNF29G29R binding has been listed below in 8 datasets. References to upper
stem, middle stem, bulge and lower stem are as indicated in Figure 3.2 B.
1. RREIIBTR_G50_2AP
In this RNA sequence the guanosine base at position 50 has been
replaced by 2 - aminopurine. The free RNA imino spectrum (Figure 3.8 A) is
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similar to that of free RREIIBTR albeit with slightly lower chemical shift dispersion
in the 13–13.5 ppm region. In the free RREIIBTR_G50_2AP, the resonances in
the vicinity of G50 (i.e., G67, U66) are broadened (Figure 3.8 A). The imino
spectrum of the RREIIBTR_G50_2AP - ZNF29G29R complex is missing one of
the new peaks at 12.65 (Figure 3.8B). This suggests that the peak at 12.65 ppm
in the RREIIBTR-ZNF complex is from the G50 – C69 base pair.

D

Figure 3.8
RREIIBTR_G50_2AP.
A. Free RREIIBTR_G50_2AP
Assignments for the free RNA
have been made on the basis of
similar chemical shifts for free
RREIIBTR.
B. RREIIBTR_G50_2AP –
ZNF29G29R 1:1 complex imino
spectrum with chemical shift
changes marked in blue and new
peaks marked in red.
C. RREIIBTR– ZNF29G29R
imino spectrum with chemical
shift changes in blue and new
imino peaks in red.
D. RNA sequence of RREIIBTR
with the affected base pairing
highlighted.

2. RREIIBTR_G70_2AP
In this sequence, the guanosine base at position 70, above the bulge, is
replaced by a 2 – aminopurine. We expect this modification to perturb the bulge
and G46 has been assigned accordingly. In complex with ZNF29G29R we see a
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downfield shift for U66 (3.9 B). Other than that there are no definitive chemical
shift changes or appearance of new peaks that can be seen in the complex imino
spectrum. It is possible that this binding event is non-specific as we see a change
only in U66 accompanied by broadening of the other imino peaks.

D

Figure 3.9 RREIIBTR_G70_2AP.
A. Free RREIIBTR_G70_2AP.
Assignments for the free RNA
have been made on the basis of
similar chemical shifts for free
RREIIBTR.
B. RREIIBTR_G70_2AP – ZNF29
G29R 1:1 complex Imino
spectrum with chemical shift
changes marked in blue.
C. RREIIBTR– ZNF29G29R imino
spectrum with chemical shift
changes in blue and new imino
peaks in red.
D. RNA sequence of RREIIBTR
with the affected base pairing
highlighted.

3. RREIIBTR_G48_71_2AP
In this RREIIBTR variant, both guanosines in the bulge are replaced by 2aminopurines. These guanosines form a base pair when Rev binds to RREIIBTR.
The free RNA imino spectrum has more similarities to free RREIIBTR than to the
previous mentioned variants. We observe a broadening of peak G46, which is
the first base pair in the middle stem, after the bulge. The complex spectrum
(Figure 3.10 B) provided no new insight and was in fact similar to the complex of
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the previous mentioned RNA variant. It is possible that this binding event is nonspecific as we see a change only in U66 accompanied by broadening of the other
imino peaks. It is however interesting to note that the intensity of the peak at
12.85 (G41 in free RNA) is lower than what has been observed for RREIIBTRZNF complex (Figure 3.6B) and similar to complex imino spectra of the 2 RNA
variants mentioned before (Figure 3.8B, 3.9B). This could indicate that there is a
new peak at that chemical shift for the RREIIBTR-ZNF29G29R complex imino
spectrum.

D

G41

Figure 3.10
RREIIBTR_G48_71_2AP.
A. Free
RREIIBTR_G48_G71_2AP.
Assignments for the free RNA
have been made on the basis of
similar chemical shifts for free
RREIIBTR.
B. RREIIBTR_G48_G71_2AP –
ZNF29G29R 1:1 complex imino
spectrum with chemical shift
changes marked in blue.
C. RREIIBTR– ZNF29G29R imino
spectrum with chemical shift
changes in blue and new imino
peaks in red.
D. RNA sequence of RREIIBTR
with the affected base pairing
highlighted.

4. RREIIBTR_G47_2AP
In this RREIIBTR variant, G47 in the bulge is replaced by a 2 aminopurine. This modification affects the base pairing for G46, G76 in the lower
stem as these peaks are absent in the free RNA imino spectrum (Figure 3.11A).
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The 1:1 complex for RREIIBTR_G47_2AP – ZNF29G29R shows no broadening
for any imino peaks and no noticeable chemical shift changes for U66 or any new
peaks. This might indicate there is no ZNF29G29R binding to this RNA variant.

D

Figure 3.11 RREIIBTR_G47_2AP.
A. Free RREIIBTR_G47_2AP.
Assignments for the free RNA
have been made on the basis of
similar chemical shifts for free
RREIIBTR.
B. RREIIBTR_G47_2AP – ZNF29
G29R 1:1 complex imino spectrum
with chemical shift changes
marked in blue.
C. RREIIBTR– ZNF29G29R imino
spectrum with chemical shift
changes in blue and new imino
peaks in red.
D. RNA sequence of RREIIBTR
with the affected base pairing
highlighted.

5. RREIIBTR_U72_3MU
In this RNA variant, a modification to U72 was made by replacing the
imino proton at N3 in the uridine by a methyl group. The U72 does not stack in
the free RREIIBTR RNA. We expected that if the peak at 11.85 ppm in the
RREIIBTR- ZNF complex spectrum belongs to U72, then it would be absent in
the RREIIBTR_U72_3MU – ZNF complex imino spectrum. There is indeed no
peak at 11.85 ppm in the RREIIBTR_U72_3MU – ZNF complex spectrum (Figure
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3.12B). Also, U66 and U45 imino resonances are shifted downfield in this
complex indicative of ZNF binding. However, we see only one (12.65 ppm) out of
the 2 peaks in this complex as compared to RREIIBTR-ZNF29G29R (Figure
3.12C). A previous experiment (Figure 3.8) has alluded the peak at 12.65 to be
G50. A plausible explanation in context with previous results could be that the
U72 stacks in the bulge on ZNF binding, but in the RREIIBTR_U72_3MU –
ZNF29G29R complex, the bulky methyl substitution disrupts G70 – C49 base
pairing. This would of course be reasonable only if our original assumption, that
the 12.60 peak belongs to G70, is true.

D

Figure 3.12 RREIIBTR_U72_3MU.
A. Free RREIIBTR_U72_3MU.
Assignments for the free RNA have
been made on the basis of similar
chemical shifts for free RREIIBTR.
B. RREIIBTR_U72_3MU – ZNF29
G29R 1:1 complex imino spectrum
with chemical shift changes marked
in blue.
C. RREIIBTR– ZNF29G29R imino
spectrum with chemical shift
changes in blue and new imino
peaks in red.
D. RNA sequence of RREIIBTR with
the base modification highlighted.
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6. RREIIBTR_C49U
This is a mutant of RREIIBTR where the cytosine at position 49 is
replaced by uridine. We expected the free RNA to form a G70 - U49 base pair
(wobble or reverse wobble) which could possibly stabilize the G50 – C69 base
pair and thus identify the G50 – C69 chemical shift. However as can be seen
(Figure 3.13A), the free RREIIBTR_C49_U and RREIIBTR have essentially
similar spectra, with the exception of a broadened G46 peak. The 1:1
RREIIBTR_C49U – ZNF imino spectrum (Figure 3.13B) shows a downfield
shifted U66. We also see a new peak close to 12.6 ppm which we have
hypothesized previously to be G70.

D

U
Figure 3.13
RREIIBTR_C49U.
A. Free RREIIBTR_C49U.
Assignments for the free RNA
have been made on the basis
of similar chemical shifts for
free RREIIBTR.
B. RREIIBTR_C49U – ZNF29
G29R 1:1 complex imino
spectrum with chemical shift
changes marked in blue.
C. RREIIBTR– ZNF29G29R
imino spectrum with chemical
shift changes in blue and new
imino peaks in red.
D. RNA sequence of
RREIIBTR with the affected
base pairing highlighted. The
C at position 49 has been
mutated to U as indicated.
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7. RREIIBTR_C69U
This RREIIBTR mutant where the C69 was changed to U69 was made
with the same intention as RREIIBTR_C49U. Its imino spectrum (free RNA) is
similar to RREIIBTR. When complexed to ZNF29G29R it shows downfield shift
for both U66 and U45 distinctly accompanied by new peaks (red). We see a new
peak at 12.62 ppm (Figure 3. 14B) which we have hypothesized to be G50.

D

U

Figure 3.14 RREIIBTR_C69U.
A. Free RREIIBTR_C69U.
Assignments for the free RNA
have been made on the basis
of similar chemical shifts for
free RREIIBTR.
B. RREIIBTR_C69U – ZNF29
G29R 1:1 complex imino
spectrum with chemical shift
changes marked in blue.
C. RREIIBTR– ZNF29G29R
imino spectrum with chemical
shift changes in blue and new
imino peaks in red.
D. RNA sequence of
RREIIBTR with the affected
base pairing highlighted. The C
at position 69 has been
mutated to U as indicated.

8. RREIIBTR_32
This RNA mutant is a 32 nucleotide RNA with the G41 - C79 base pair
missing (i.e. the 5’ end starts with G42). The imino data from the complex
spectrum of this RNA with ZNF29G29R corroborates the presence of a peak
overlapped with the G41 peak. RREIIBTR_32 binds ZNF29G29R and produces
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the same chemical shifts (blue) and new peaks (red) as in RREIIBTR –
ZNF29G29R binding. As can be seen, there is indeed another peak (Figure
3.15B, blue arrow) between G64 and G76 in the complex spectrum. In the
RREIIBTR – ZNF complex this chemical shift (12.85) belongs to G41. The
RREIIBTR_32 mutant does not have a G41 – C79 base pair, and hence should
not show any peak at this chemical shift.

D

Figure 3.15 RREIIBTR_32.
A. Free RREIIBTR_32.
Assignments for the free RNA
have been made on the basis
of similar chemical shifts for
free RREIIBTR.
B. RREIIBTR_32 – ZNF29
G29R 1:1 complex imino
spectrum with chemical shift
changes marked in blue.
C. RREIIBTR– ZNF29G29R
imino spectrum with chemical
shift changes in blue and new
imino peaks in red.
D. RNA sequence of
RREIIBTR with the missing
base pairing highlighted.

The information from the aforementioned 8 data sets can be summarized
as follows.
a. The 2-aminopurine modification in all RNA variants with the exception of
RREIIBTR_G50_2AP affects the stability of the entire RNA as evidenced
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by lower chemical shift dispersion and broader peaks (free RNA). While
modifications of G70 and G48-G71 resulted in non-specific binding, the
G47 modification seemed to have completely abrogated RNA – protein
interactions. This would indicate G47 to be crucial for RREIIBTR-ZNF
binding.
b. Out of the 2 new peaks, the peak at 12.65 ppm belongs to G50 as shown
by dataset 1. Datasets 6 and 7 seem to indicate that the mutated
nucleotide does not form a G – U base pair even after ZNF binding. If this
is indeed true then the peak at 12.60 ppm is G70.
c. The RNA mutants (datasets 6 and 7) showed that mutations to U in the
middle stem did not result in a loss of binding.
d. The new peak at 11.85 ppm could possibly belong to U72 if the
assignment of G70 is correct.
e. There is a peak under the G41 peak in the imino complex spectra whose
identity has not been established. This would raise the tally of new RNA
imino peaks on ZNF binding to 4.
A definitive agreement on the identity of these imino peaks can be only
established by a 15N HSQC spectrum of isotopically labeled RREIIBTR.

RREIIBTR – ZNF mutants
We have compared the binding of all ZNF mutants (Table 2.2) to
RREIIBTR (Figure 3.16). Disregarding the minor differences, the complexes of
ZNF29, ZNF29G29R, ZNF29H6A, ZNF29H6K, ZNF29R12A, ZNF29N21A,
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ZNFN21Q had similar imino spectra as evidenced by the changes in chemical
shift (blue box) and the new peaks (mauve boxes). The imino spectrum for
ZNF29N21Q – RREIIBTR binding did not produce the peak at 11.85 ppm though
we see the chemical shift changes for U66 and U45 as well as the supposed G50
and G70 peaks (overlapped). This is in contrast to the ZNF29N21A whose
complex imino spectrum is similar to ZNF29G29R binding. It can be inferred that
the presence of a larger amino acid, glutamine as opposed to asparagine or
alanine, at position 21 disrupts the formation of the base pair (11.85 ppm) or
intermolecular contact. The other marked differences can be seen in the
complexes of ZNF29N15A and ZNF29D16A. ZNF29N15A did not produce a
change in chemical shift of U45 on binding, whereas in the case of ZNF29D16A,
U66 and U45 resonances are overlapped. It is also interesting to note that both
mutants display only one of the new base pairs (G50 or G70) in their spectra.
This would indicate that the binding orientation of the zinc finger postures its “tip”
(N15, D16) closer to the middle stem of RREIIBTR (G50, G70). We can also
observe that in contrast to the imino spectra for ZNF29G29R - RREIIBTR
complex, all other complexes had broader peaks. This can be attributed to a
slightly higher off rate (koff) or a lower on rate (kon) for these mutants binding
RREIIBTR compared to ZNF29G29R. Hence, these mutants are expected to
bind RREIIBTR with higher values of dissociation constant (Kd), or in other words
have lower affinity for RREIIBTR than ZNF29G29R. None of these mutations
however, resulted in complete loss of RNA binding capability. We have also
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studied the energetics of interaction with RREIIBTR for all ZNF mutants by ITC in
the following chapter.
1

2

3

4

Figure 3.16 RREIIBTR – ZNF mutants imino spectra.
1 (blue highlight) - changes in U66 and U45
2 (mauve highlight) - new peak overlapped with G41
3 (mauve highlight) - new peaks G50 and G70
4 (mauve highlight) – new “U72” peak
All the above experiments were conducted at ~ pH 7.0 and 298 K.
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Protein tertiary structure dependent RNA binding
We have deduced the role of the tertiary structure of the ZNF protein in
RNA binding by adding excess EDTA to the complex. The presence of zinc is
important for the sustenance of the !!" motif of the ZNF (3) which is destroyed
by EDTA chelation. If the onus of binding RNA were to lie solely with the ZNF
protein sequence then we would expect to see no change in the imino spectrum
of the complex upon addition of EDTA. However we observe that the imino
spectra of the complex returns to its free from, albeit in an extended period of
Figure 3.17 Structure
dependent binding.
5 mM EDTA was added
to a100 µM RREIIBTR ZNF29G29R 1:1
complex. Spectra was
collected at 15 min, 10 h,
45 h after EDTA
addition. pH was
checked at each time
interval and was found to
be ~ 7.0. Blue dashed
lines trace the ZNF
bound RNA by U66 and
U45 downfield shifted
chemical shifts. Black
dashed line indicates the
chemical shift of the U66
in free RNA. Red dashed
lines trace the new imino
peaks of the bound
RNA.

time (Figure 3.17), after addition of EDTA. This demonstrates that the !!"
scaffold of our zinc finger proteins (properly folded ZNF) is required for
RREIIBTR binding as is the identity of amino acids on that scaffold. It is also
noteworthy that it takes more than 10 h for EDTA to chelate the zinc and unfold
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the protein when bound to RNA whereas it takes less than 15 min to do the same
for free protein.

Temperature stability of the complex
The stability of the ZNF29G29R – RREIIBTR complex was monitored in
the temperature range of 283 – 313 K. We observe that the complex is stable up
until 308 K, but starts to dissociate between 308 – 313 K (Figure 3.18). This
effect was found to be reversible, as we observe the reappearance of the imino
peaks indicative of binding, on returning to 298 K.
Figure 3.18
Thermal stability of
the complex.
Imino spectra
overlay of a 100 µM
RREIIBTR ZNF29G29R 1:1
complex. Spectra
was collected for the
range 283 – 313 K
and then brought
back to 298 K. Blue
highlighted box
follows U66 and U45
while the mauve
highlighted boxes
follow the new imino
peaks indicative of
ZNF bound
RREIIBTR.
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Salt effects on the complex
The complex showed stability up to 500 mM NaCl (data not shown) as it
maintained the elements of the imino spectrum that indicate binding. The
complex stability in the NaCl concentration range (50 - 200 mM) is displayed
below in Figure 3.19.
Figure 3.19 Effect of salt on the
complex.
Imino spectra overlay of a 100 µM
RREIIBTR - ZNF29G29R 1:1 complex with
increasing salt conditions. Respective salt
concentrations were achieved by adding
NaCl from a 1 M stock solution. pH was
adjusted and maintained at ~ 7.0. Blue
highlighted box follows U66 and U45 while
the mauve highlighted boxes follow the
new imino peaks indicative of ZNF bound
RREIIBTR.

Binding orientation
The !!" motif of the ZNF, in its entirety, can be represented by a cylinder,
where the N-terminus and the tip of the zinc finger denote one end of the cylinder
and the C-terminus denotes the other. The binding of this “cylinder” to the RNA
bulge can have 2 orientations (Figure 3.20). The zinc coordination in our ZNF is
located closer to the C-terminus of this “cylinder”. This is to our advantage as we
have replaced the zinc by a paramagnetic metal viz. Co2+ (which has a
coordination geometry similar to Zn2+) and monitored the “cobalt loaded” ZNF RREIIBTR binding by imino NMR.
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Figure 3.20 Plausible ZNF binding
orientations.
ZNF29G29R (pdb id 2AB7) was
fitted manually to RREIIBTR bulge in
iMol (14). The RREIIBTR used in this
model is the bound form (RREIIBTRRev peptide, pdb id 1g70) (15). The
free RNA structure of RREIIBTR has
not been submitted to the PDB
database. The bound Rev peptide
was replaced with ZNF29G29R
using iMol. The manual fitting was
done visually and any overlap of the
2 biomolecular backbones was
prevented.

A “cobalt loaded” ZNF was achieved in the following manner. A 250 µM
solution of synthetic unfolded ZNF28 (Genscript Corp.) was made in buffer: 10
mM NaP, 100 mM NaCl, 250 µM !me, pH 6.8. The folding of the ZNF28 by Co2+
was observed by UV peaks at 640 nm and 580 nm. The final concentration of the
cobalt folded protein was calculated by the extinction coefficients at 640 and 580
nm which are 820 M-1 cm-1 and 300 M-1 cm-1 respectively. The pH was
maintained at 6.8 ± 0.1 throughout the titration. Final concentration of Co2+ added
to the unfolded protein was 400 µM (Figure 3.21). The peaks at 640 nm and 580
nm are due to the intense d-d absorption bands exhibited by optical transitions of
a tetrahedral Co2+ species (4). The intense absorption bands at 316 nm and 320
nm are due to S- - Co(II) ligand to metal charge transfer transition (5). The
extinction coefficient of the 320 nm band indicates the number of thiolate groups
coordinated to the metal and averages 900-1200 M-1 cm-1 per S- - Co(II) bond.
The concentration of the Co2+ folded ZNF28 was ~ 220 µM. Using this value of
concentration, and an absorbance value of 0.5 (Figure 3.22) for 320 nm band,
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the extinction coefficient of the 320 nm band is calculated to be in the range of
2272 M-1 cm-1, indicating ~ 2 thiolate groups coordinated to the metal. A blank
sample containing an equivalent amount of Co2+, but no protein, did not have any
of the above mentioned peaks, thus establishing that the Co2+ was tetrahedrally

Abs (640 nm)

coordinated to the cysteines and histidines of the protein.

2+

Co Concentration µM

2+

Figure 3.21 Titration of unfolded ZNF28 with Co .
UV - visible monitoring of ZNF28 folding by cobalt. A stock solution of 1 M cobalt(II) chloride
hexahydrate was used for titration. The cobalt stock solution was made in 10 mM NaP, 100 mM
NaCl, pH 6.8.
2+
(Inset) Absorbance at 640 nm plotted against Co concentration showing saturation at ~ 220 µM.

Excess cobalt from the cobalt folded protein solution was removed by DSalt ExcelluloseTM column as mentioned in Chapter 2. A UV spectrum of the final
protein (Co2+ folded) stock solution is shown in Figure 3.22.
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Figure 3.22 UV - visible
spectrum (300 - 800 nm) of
“cobalt loaded” ZNF28.

A titration of RREIIBTR with Co-ZNF28 broadened all peaks (Figure 3.23).
This might be due to free cobalt in solution despite our efforts to remove it by
desalting. Addition of only cobalt to free RNA in equimolar quantity produced
similar results in the imino spectra (Figure 3.23E). In order to address this issue,
we used a mixture of cobalt folded and zinc folded protein for RNA titration. This
mixture consisted of 15% of cobalt folded ZNF28 of the total protein
concentration while the rest was zinc folded protein. The above combination
produced more discernable changes (Figure 3.24) that has allowed us to identify
the proximity of certain base pairs to the metal coordination site in the protein.
The 15% Co2+ folded ZNF28 titration mainly affected (broadening due to
paramagnetic relaxation effects) (6), the bases in the lower stem of the RNA on
biding: U45, G42, G77. It is not clear whether U43 and G46, also in the lower
stem, are broadened. Interestingly, the peak that we believe is G70 is also
broadened. G70 - C49 is at the top of the RNA bulge (middle stem) and is closer
to the coordinated cobalt on ZNF binding than the G50 – C69 base pair. Based
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on the above data we can infer that the binding orientation is the one proposed in
Figure 3.20 B, which is in agreement with the imino data in Figure 3.16.

Figure 3.23 RREIIBTR – ZNF28
(100% cobalt folded).
RNA concentration is 100 µM
A. Free RREIIBTR,
B. 1:1 RREIIBTR : ZNF28 (100%
zinc folded),
C. 1:1 RREIIBTR : ZNF28 (100%
cobalt folded),
D. 1:1 RREIIBTR : Cobalt(II)
chloride. The pH was adjusted
and maintained at ~ 7.

Figure 3.24 RREIIBTR – ZNF28
(15% cobalt folded) titration.
RNA concentration is 100 µM
A Free RREIIBTR
B 1:1 RREIIBTR : ZNF28 (100%
zinc folded)
C 1:0.5 RREIIBTR : ZNF28 (15%
cobalt, 85% zinc folded)
D 1:1 RREIIBTR : ZNF28 (15%
cobalt, 85% zinc folded)
pH was adjusted and maintained at
~ 7.
The orange boxes highlight the
most affected (paramagnetic
relaxation broadened) peaks on
titration. The G70 resonance is
marked with a * since it is a
tentative assignment.
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Figure 3.25 provides a better perspective by highlighting the cobalt center in the
protein and the bases that show broadening in the imino spectrum (Figure 3.25).

Figure 3.25 RREIIBTR - ZNF29G29R binding model.
(A and B) Different perspectives of the RREIIBTR – ZNF29G29R binding model.
This model is based on the data from Figure 3.24. The RNA backbone is in light grey.
The RNA residues affected by paramagnetic relaxation, which have been identified in
Figure 3.24, are marked in red on the RNA backbone. RNA residues that donot show
any effects, and could be identified unambiguously, are marked in lime green on the
RNA backbone. The G70 resonance is marked with a * since it is a tentative
assignment. The coordinated cobalt is displayed as a blue sphere. This graphic was
rendered in iMol (14).

Tertiary structural changes in ZNF on binding RREIIBTR
We have examined the changes in the protein amide backbone on
RREIIBTR binding by

15

N HSQC NMR spectra. The

15

N HSQC for the complex

(Figure 3.26B) has broader peaks than its free counterpart (Figure 3.26A), as
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expected. This occurs due to increased rotational correlation time of the RNA
bound ZNF, resulting in larger linewidth. An overlay of the free and bound forms
of the ZNF is displayed in Figure 3.27. As can be seen, there are no drastic

A

Figure 3.26 Protein
amide backbone
15
A. N HSQC spectra of
free ZNF29G29R (fully
15
N labeled).Assignments have been published
previously (13).
15

B. N HSQC spectra of
15
ZNF29G29R (fully N
labeled) bound to
unlabeled RNA.
Both spectra were
acquired by 2D HSQC
pulse sequence using 39-19 pulse sequence
with gradients (12, 16)

B

changes in the spectra, but changes that do occur are mostly limited to the " helix, which spans residues 17 – 29. The residues in the ! sheet have very
minimal changes if any. The only other residue of interest that has changes in its
chemical shift is N15 which occupies the tip of the zinc finger. Residues 5, 10,
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14, 20, 23, 27 consitute the hydrophobic core of the ZNF. Residues 5, 10, 14 and
20 maintain identical chemical shifts in their free and bound forms while 23 and
27 show minor changes.

15

Figure 3.27 N HSQC overlay of free and RREIIBTR bound ZNF29G29R.
Boxes (dashed) mark resonances with large chemical shifts. Black filled triangles mark the
residues that constitute the hydrophobic core. Circles (dashed) mark residues with minor
chemical shift changes.

Conclusion
Our ZNF proteins bind RREIIBTR at its bulge region, the same location
that Rev utilizes (2). However the imino spectrum of RREIIBTR - Rev and
RREIIBTR - ZNF29G29R is markedly different indicating a different mode of
binding. We observe the changes in chemical shift of U66 and U45 on ZNF
binding and note that the phosphates of these nucleotides border the entrance to
the major groove of the RNA, at the bulge (Figure 3.29). RREIIBTR –
ZNF29G29R binding was found to be specific and had 1:1 stoichiometry. In
contrast to other peptides (7) that have been designed to bind RREIIBTR, these
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ZNF’s bind only when folded in their !!" motif. The aforementioned designed
peptide is a random coin in solution (7) and adopts a secondary (helical)
structure only after binding RREIIBTR. We have also established that our ZNF’s
utilize amino acids constituting the " helix and the tip of the finger in its molecular
interaction with the RNA (Figure 3.28). This is akin to other zinc finger proteins
involved in RNA binding. In fact, the starting scaffold for phage display that
ultimately resulted in the ZNF’s that we are currently studying (8), the 4th zinc
finger of TFIIIA, also uses the same elements of its secondary structure in
binding RNA (9,10).

Figure 3.28 ZNF29G29R residues affected
by RNA binding.
ZNF29G29R tertiary structure (free protein
pdb) displayed with the amino acids displaying
15
1
large changes in amide ( N, H) chemical shift
marked in red, moderate changes in chemical
shift marked in blue and no changes in
chemical shift in grey. The amino acids whose
amide resonances could not be identified in
Figure 3.27 are marked in black. The
coordinated zinc atom is in yellow.This graphic
was rendered in iMol (14).

U66

U45

Figure 3.29 RNA phosphate
backbone.
(left) RREIIBTR RNA (pdb id
1g70) phosphate backbone at
the bulge with residues (U66,
U45) that are at the entrance to
the major groove (wite arrow).
This graphic was rendered in
iMol(14).
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CHAPTER 4 Energetics of RREIIBTR - ZNF binding
Introduction
The molecular driving forces in biomolecular interactions can be better
understood by evaluating the thermodynamic parameters for that particular
system viz. free energy, enthalpy, entropy and specific heat of binding. These
thermodynamic parameters for the ZNF - RREIIBTR system have been
determined using isothermal titration calorimetry (ITC). We have studied the
binding of ZNF mutants to RREIIBTR, ZNF29G29R to RREIIBTR mutants and
and ZNF29G29R – RREIIBTR binding under differing conditions of pH, salt
(anions and cations), temperature, osmolytes and buffers.

Binding constants from gel shift assays
We have previously reported the binding of ZNF29 and ZNF29G29R with
RREIIB, as determined by gel shift assays (1). It was observed that under those
conditions reported, we see a very minor shift in the RREIIB – ZNF complex on
the gel as compared to the free RNA. As a result, a competition assay was used
to determine the dissociation constants for the above-mentioned proteins. The
gel shift experiments were reevaluated and we observe a shifted band for the
complex under current conditions. The RNA in the current gel shift experiment
was RREIIBTR, since it was the RNA used in NMR structure determination.
Free and ZNF bound samples were run on a 15% native PAGE gel at 110
V at room temperature. The running buffer was tris borate buffer (0.5X), made
from a 10X stock (108 g Tris base, 55 gm boric acid, pH adjusted to 8.0, in a liter
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of deionized water). All samples were made in 10 mM sodium phosphate, 50 mM
NaCl, 200 µM !me and loaded with 5 µl of 60% sucrose solution (total sample
volume 25 µl). The running buffer was degassed before use and the gel was
prerun at 110 V for an hour before loading the samples. Subsequently, the gel
was stopped when the bromophenol blue band (loaded in the same lane as free
RNA) had migrated to the end of the gel. The gel was then stained in 50 ml of
running buffer containing a 1:10,000 dilution of SYBR Green II (Invitriogen) for 45
min in a covered container, followed by scanning on a Typhoon fluorescence
scanner (Amersham Biosciences). The intensities of the gel bands were
quantitated by Imagequant TL, v1.0 software (Amersham Biosciences). The free
RNA band in lane 1 was normalized to 1. For the RNA - protein samples (lanes 2
- 10), the free RNA band (blue dashed line) was used to estimate the amount of
free RNA, and consequently the fraction of bound RNA, with increasing protein
titrations (Figure 4.1).
The fluorescence intensities of the complex (Figure 4.1 A, red dashed line)
are lower than that of the free RNA. This could be attributed to a decrease in the
number of binding sites available for SYBR Green II molecules on the ZNF
bound RNA, as compared to the free RNA. Additionally, fluorescence quenching
of SYBR Green II molecules bound to the RNA – ZNF complex can also
potentially decrease the intensity of the bands. Therefore, we have utilized the
fluorescence intensities of the free RNA band for our calculations.
A plot of the fraction of bound RNA ($) vs protein concentration [P] was
used to calculate the dissociation constant (Kd), by fitting the data to a 1:1
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binding model in Kaleidagraph, v3.6. The equation used for fitting was as follows:
$ = [P] / ([P] +Kd)
where $ is the fraction of ZNF bound RNA,
Kd is the dissociation constant,
[P] is the concentration of the free ZNF29.
The Kd for ZNF29 – RREIIBTR binding was determined to be 27 ± 3 nM by gel
shift assay, under the current conditions: 50 mM NaCl, pH 8.0 and 298 K.
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A

ZNF29 - RREIIBTR
Free RREIIBTR

1

2

3

4

5

6

7

8

9

10

B
Z29 (M)
0
1.10E-08
2.15E-08
3.03E-08
4.13E-08
6.15E-08
8.03E-08
1.05E-07
1.56E-07
2.52E-07

$
0
0.18
0.37
0.52
0.68
0.74
0.78
0.85
0.89
0.92

(M)
Figure 4.1 ZNF29 – RREIIBTR gel shift assay.
A. Picture of the gel shift assay as obtained from the Typhoon fluorescence scanner
and analyzed by the Imagequant TL v1.0 software. RNA (RREIIBTR)
concentration was 50 nM with increasing protein (ZNF29) concentration from left
to right. The ZNF29 concentrations are listed in the table next to Figure 4.1 B.
B. Curve fit of the data from A in Kaleidagraph software v3.6. The red box (inset)
displays the fitting parameters: y is $, m0 is [P] (free ZNF29 ) and m1 is Kd.
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Energetics from Isothermal titration calorimetry
a. RREIIBTR – ZNF mutants
We have determined the thermodynamic parameters involved in the
binding of all the ZNF mutants listed in Table 2.1, to RREIIBTR, by ITC. All ITC
experiments mentioned henceforth were done under the following conditions
unless mentioned otherwise. Calorimetric titrations were performed on a VPITC
microcalorimeter (Microcal Inc.) by injecting 10 µl of the respective protein into
the respective RNA solution (5 µM) every 600 s until saturation occurred. The
VPViewer 2000 (Microcal Inc.) was used for data collection and Origin 7.0
(OriginLab) was used for curve fitting. The protein concentrations in the syringe
were in the range of 70 - 75 µM and were determined by NMR as mentioned
previously. The pH values of protein and RNA solutions used were adjusted to
have a difference smaller than 0.05 units. The first data point was obtained by a
1 µl protein injection into RNA and was discarded since it contained errors due to
diffusion. The heats obtained were corrected for heat of dilution of the titrant
(protein), by subtracting a straight line consisting of the data points that indicated
binding saturation, in the Origin software, before curve fitting. In experiments
where saturation was not apparent, heats of dilutions were obtained separately
by injecting protein into buffer under respective conditions of the protein-RNA
titration. Finally the stoichiometry Ka (association constant), dH (enthalpy) and dS
(entropy) were obtained by curve fitting to the relevant binding model in Origin
7.0.
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All ZNF mutants – RREIIBTR ITC data had similar binding isotherms
(Figure 4.2) and could be fit to a 1 : 1 binding model. The

thermodynamic

Figure 4.2 Binding isotherm for
ZNF29G29R titrated into RREIIBTR.
ZNF29G29R - RREIIBTR binding as
followed by ITC at 298 K and pH 7.0.
The protocol for the experiment is
mentioned above. The binding
isotherm was baseline corrected and
the peaks were integrated. A 1:1
binding model was used to fit the data
obtained, in Origin 7.0 software and
yielded the values of the association
constant (Ka), the enthalpy (%H) and
the stoichiometry (n). The software
also calculated the value for the
entropy (%S) using the relation %G =
%H -T%S, where %G is the Gibbs free
energy and is related to Ka by the
equation %G = -RTln(Ka). The value of
-1 -1
R is 1.987 kcal mol K .

parameters for these titrations are displayed in Table 4.1.
As can be seen, ZNF29G29R had the lowest Kd or in other words, the
highest affinity to RREIIBTR. ZNF29G29R differs from ZNF29 only in the C
terminal arginine but binds RREIIBTR in the same manner as evidenced by the
imino spectra. The higher binding affinity for ZNF29G29R likely indicates
interaction of the terminal arginine residue with the RNA phosphate backbone.
The ZNF29H6A and ZNF29H6K mutations were studied to query whether
the histidine at position 6 made any specific interaction and if so, whether that
interaction was due to aromatic stacking between the histidine and a RNA base.
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Table 4.1 ITC binding data for RREIIBTR – ZNF mutants binding.

Protein

n

Kd

%G

-T % S

%H

kcal mol
-9.23 ± 0.88
-9.83 ± 0.57
-9.07 ± 0.72

-1

kcal mol
-7.61 ± 0.14
-5.30 ± 0.09
-5.40 ± 0.13

-1

kcal mol
-1.61
-3.55
-3.67

-1

ZNF29
ZNF29G29R
ZNF29H6A

0.97
1.00
0.99

nM
170 ± 20
62 ± 12
222 ± 34

ZNF29H6K

1.01

95 ± 24

-9.57 ± 0.44

-4.30 ± 0.10

-5.27

ZNF29R12A

0.99

538 ± 87

-8.55 ± 0.68

-6.50 ± 0.31

-2.04

ZNF29N15A

1.04

271 ± 39

-8.95 ± 0.75

-7.62 ± 0.18

-1.33

ZNF29D16A

0.98

383 ± 39

-8.75 ± 0.95

-7.83 ± 0.15

-0.92

ZNF29N21A

0.98

232 ± 35

-9.05 ± 0.72

-6.65 ± 0.16

-2.40

ZNF29N21Q

0.95

81 ±25

-9.67 ± 0.33

-7.71 ± 0.22

-1.96

ZNF28

0.98

172 ±68

-9.22 ± 0.21

-4.90 ± 0.16

-4.23

The RNA used in the sample cell was RREIIBTR, while the protein in the syringe is as
mentioned in the table above. All experiments were conducted at 298 K. The buffer
conditions for RNA and protein are: 10 mM sodium phosphate, 100 mM NaCl, 200 µM
!me, pH 7.0. The binding affinities are expressed in the form of the dissociation constant
Kd = 1/Ka.

We observe an increased binding affinity for ZNF29H6K over ZNF29, while the
ZNF29H6A mutant has a slighty reduced affinity. This implies that the RNA –
ZNF interaction at the H6 position is not due to stacking, because if it were so,
we would expect a reduction in affinity for both mutants (H6A and H6K mutations
correspond to the absence of an aromatic side chain). The ZNF29R12A mutant
had the lowest binding affinity, although the imino spectra for RREIIBTR bound to
the ZNF29R12A and ZNF29, are similar. We also observe that the imino spectra
of RREIIBTR bound to ZNF29, ZNF29H6A and ZNF29H6K are similar (Figure
3.16), but show differences in their binding affinity. Since imino spectra represent
the binding interface inside the major groove (RNA base pairing), differences in
binding affinity for these mutations (H6A, H6K and R12A) indicate their
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involvement in contacts with the RNA phosphate backbone or the ribose sugars.
We note that the H6 and R12 residues are diametrically opposite on the ! sheet
and if the " helix of the ZNF is positioned inside the major groove of the RNA,
these side chains are aligned to form potential contacts with the phosphate
backbone (Figure 4.3).

Figure 4.3 ZNF binding RREIIBTR in
the major groove at the bulge.
A cartoon representation displaying the
alignment of ZNF29G29R in the RNA
major groove such that H6 and R12 can
make contacts with the phosphate
backbone (red filled circles). The protein
structure was rendered from the pdb for
ZNF29G29R (id 2AB7) in iMol (2).

The mutations at the tip of the ZNF viz. ZNF29N15A and ZNF29D16A also
have reduced affinities. Zinc fingers are known to make contacts with their tips
and these reduced affinities indicate their involvement in binding. The D16A
mutation can reduce the binding affinity in two ways:
a. The D16A mutation affects RNA binding directly, due to the absence of a D16
– RNA contact.
b. The D16A mutation affects RNA binding indirectly by influencing the position of
the K19 sidechain in the complex, and consequently the binding contributions
from K19. This is plausible since the amide proton of K19 is hydrogen bonded to
the carbonyl oxygen of the D16 sidechain (Figure 4.4). The presence of the
aforementioned D16 – K19 hydrogen bond was established, by the software
SwissPdbviewer (3), in the solution structure of the free ZNF29 (pdb id 2AB3).
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The mutations N21A and N21Q had opposite effects on binding. In
comparison to ZNF29, the N21A mutation reduced the binding affinity slightly
while the N21Q mutation had a 2-fold increase in binding affinity. The N21
position is located at the protein - RNA interface inside the major groove of the
RNA and hence mutations at this position can affect RNA base pairing in the
complex. We observe that the RREIIBTR - ZNF29N21A imino spectrum is similar
to that of RREIIBTR - ZNF29, while in the case of RREIIBTR - ZNF29N21Q, we
are missing the peak that could correspond to U72 (Figure 3.16). The reduced
affinity for the N21A mutation and the imino data (RREIIBTR – ZNF29N21A)
indicate that the asparagine at position 21 contacts the RNA at elements other
than base pairs (possibly ribose sugars). We note that when the asparate at
position 21 is replaced by a longer side chain (glutamine), the carbonyl oxygen of
the glutamine side chain can potentially form a hydrogen bond with the # proton
of the R17 sidechain (Figure 4.4). The presence of this hydrogen bond was
established by SwissPdbviewer (3), from an in silico mutation (N21Q) of the free
ZNF29 solution structure (pdb id 2AB3). Thus the increased affinity of
ZNF29N21Q over ZNF29 could be a contribution from different positioning of the
R17 side chain in ZNFN21Q than ZNF29.

A

B

Figure 4.4 Hydrogen bonding of the amino
acid side chains in ZNF29.
A. A hydrogen bond between the carbonyl
oxygen of the D16 sidechain to the backbone
amide proton of K19.
B. A hydrogen bond between the carbonyl
oxygen of the N21 sidechain to H# of R17.
The
N21Q
mutation
was
made
in
SwissPdbviewer from ZNF29 (pdb id 2AB3)
and energy minimized (3).
SwissPdbviewer was also used to determine
the hydrogen bonds in A and B.
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ZNF28 did not show any difference in binding affinity compared to ZNF29.
The enthalpy and entropy contributions to the free energy of binding for all these
mutants are discussed in detail later.

b. Specific heat of binding
We have studied the temperature dependence of enthalpy to determine
the specific heat of binding. For all further experiments, the ITC experiments
used ZNF29G29R as the protein and RREIIBTR as the RNA, unless mentioned

kcal/mol

otherwise.

K

Figure 4.5 Enthalpy - entropy
compensation and specific heat of
binding.
The specific heat of binding is given by
%Cp = #(%H)/#T. The linear regression
fit of the enthalpic dependence on
temperature yielded a slope of -0.2962
-1 -1
kcal mol K .

The free energy of ZNF – RREIIBTR binding has favorable contributions
from both enthalpy and entropy components. The enthalpy – entropy
compensation in the temperature range 288 – 308 K leaves the free energy %G
in a range of -9.46 to -9.90 kcal/mol. It has been noted in the previous chapter
that the complex, free ZNF29G29R and RNA are stable in this temperature
range. Therefore we do not have to consider contributions to the free energy
from thermal denaturation of these 2 components. We observe that the linear
relationship of enthalpy and entropy to temperature also confirms that the binding
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components of this system do not unfold in the studied temperature range. It has
been observed in thermodynamic studies of biomolecular systems that this
relationship is non-linear in cases when one or both biomolecules unfold in
temperature ranges studied (4). From the linear dependence of enthalpy on
temperature, the specific heat of binding (%Cp) is calculated to be -0.296 kcal
mol-1K-1 (Figure 4.5). The negative %Cp in biomolecular interactions has been
linked to the extensive dehydration of non-polar (%Anp) compared to polar
surfaces (%Ap), either by the conformational rearrangement of the interacting
molecules or by burial of nonpolar interfacial surfaces (5,6). This surface
dehydration contribution to %Cp is described by the equation 4.1.
%Cp = "%Anp - !%Ap

(4.1)

where " and ! are numerically positive proportionality coefficients (6,7,8,9).
The accessible surface area (ASA) (polar and nonpolar) for the free protein, free
RNA and the complex has been calculated in Table 4.2.
We see that on binding, more polar than nonpolar surface is buried upon
complex formation (Table 4.2). The disparity in accounting for negative %Cp by
area models that focus on nonpolar surface dehydration alone is also reported in
several studies (4, 11). To provide a rationale, Cooper has proposed a different
approach in interpreting %Cp values. The nature of %Cp is attributed to
“cooperative transitions of a multiplicity of weak interactions – regardless of the
nature of the interaction” (11).
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Table 4.2 Accessible surface area (ASA) of protein, RNA and complex.
2

2

2

2

ASA

ZNF29G29R (Å )

RREIIBTR (Å )

Complex (Å )

%(Å )

Anp

1225.52

1924.89

2296.09

-854.32

Ap

2156.66

5080.65

5005.94

-2231.37

The ASA’s (polar and non-polar) have been calculated by the program Surface Racer (10) with a
probe radius of 1.5 Å. The pdb file for ZNF29G29R was 2AB7. The free RNA structure of
RREIIBTR has not been submitted to the PDB database. So, the pdb for free RNA was created
from the Rev bound RREIIBTR (pdb id 1G70) by manually deleting the Rev peptide from the
complex in iMol (2). The pdb used for ZNF29G29R complex was created by manually fitting the
free protein (2AB7) into the major groove of the free RNA (previous created pdb from 1G70). The
helix of ZNF29G29R was placed in the major groove of the RNA, since we have shown the
interaction with RREIIBTR is primarily through the helix and the tip of the ZNF (Figure 3.27).
-2
2
2
2
%(Å ) = Complex (Å ) – [RREIIBTR (Å ) + ZNF29G29R (Å )]

He has argued based on models and theoretical calculations that:
A. The binding of a ligand to a macromolecule with water involvement in the
macromolecular cavity / interface will be more exothermic than one that
displaces all water at the cavity / interface.
B. The %H and %Cp calculations for these 2 schemes, macromolecular ligand
binding involving water (Scheme 1) and excluding water (Scheme 2),
result in the following equations.
%Cp ~ -4h#f/ #T

(Scheme 1)

%Cp ~ -xh#f/ #T

(Scheme 2)

where h is the enthalpy of hydrogen bonding (macromolecular – water,
ligand –water, water – water, macromolecular – ligand).
f is the fractional occupancy of water molecules at the macromolecule
binding site, the ligand binding site and the fraction of water – water bonds
in the bulk solvent.
T is the temperature.
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x is the number of macromolecule – water hydrogen bonds at the ligand
binding site.
These models are based on the assumption that all hydrogen bonds
having equal heats of formation and fractional occupation have similar values, for
simplification. In both the above Schemes, h and #f/#T have negative values
(enthalpy of hydrogen bond formation ~ -3 to -6 Kcal/mol, and f decreases with
increase in temperature), resulting in negative %Cp values. This corresponds to
the negative %Cp observed in the RNA - ZNF system.
These Schemes also rationalize the trend in %H values for ZNF29 and its
mutants. The decrease in enthalpy, for ZNF29G29R binding to RREIIBTR as
compared to ZNF29, is inconsistent with the presence of a polar amino acid
(arginine). However, as evident from Figure 4.7, the molecular volume of arginine
is much larger than glycine. Consequently, the binding of ZNF29G29R would be

Figure 4.6 Enthalpy and entropy of all ZNF mutants binding RREIIBTR.
The data is in the order of decreasing enthalpy (less exothermic)
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Figure 4.7 Electrostatic surface potential of ZNF29G29R and molecular volumes.
Electrostatic surface potential mapped on the molecular volume of ZNF29G29R (A) with the
terminal amino acid outlined by a dotted white circle. Wire frame and secondary structure
representation of ZNF29G29R (B) and ZNF29 (C) with the C terminus amino acid side chain
outlined by a blue dotted circle. Electrostatic potential was calculated by solving the nonlinear
Poisson Boltzmann equation by the software APBS (21, 22) and mapped onto the molecular
volume in the visualization software PMV (20).

expected to displace more water than ZNF29. Similarly, in the cases of mutations
of H6, R12 to smaller amino acids (H6A, R12A), we expect lower surface
dehydration of the RNA major groove than for bulkier replacements (H6K). All
these amino acid sidechains will be located closer to the RNA phosphate
backbone with the protein helix in the major groove.

We hypothesize that,

mutations from bulkier side chains to smaller ones will show a difference in
enthalpy as we see in Cooper’s models, Scheme 2 versus Scheme 1. Cooper’s
models and calculations predict that the macromolecule binding ligand with the
entrapment of water (Scheme 1) are more exothermic than the model in which
there is a lesser degree or no entrapment of water. Though all effects on the
enthalpy cannot be attributed to displacement of water from the major groove
alone we observe such a trend in the enthalpies of binding of the ZNF mutants.
The enthalpies of mutants with bulkier side chains ZNF29G29R and ZNF29H6K
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are less exothermic than ZNF29 and ZNF29H6A respectively. ZNF29R12A is
less exothermic than ZNF29 but is still more exothermic than ZNF29G29R, a
ZNF with higher molecular volume. The mutants ZNF29N15A and ZNF29D16A
do not show any differences in binding enthalpy as compared to ZNF29, although
they show different binding interactions as evidenced by the imino NMR studies
(Figure 3.16). This would indicate that the part of the interface involving the
positions N15 and D16 is deeper in the major groove and a mutation to alanine
hampers their binding potential but still allows the mutants to offer a similar
dehydration of the major groove, as ZNF29. Imino NMR data also showed that
ZNF29N21A has a similar binding interface as ZNF29 but we observe a lower
exothermic binding for ZNF29N21A and a slightly higher value for ZNF29N21Q
as compared to ZNF29. In context of the imino data, we hypothesize that
although the asparate does not directly participate in binding, a mutation to
glutamine allows increased access to the major groove. We do not see a
correlation between enthalpy and molecular volumes of all mutants. However, we
also note that these mutants are missing sidechains that potentially interact with
the RNA. This would explain why ZNF28, which has a smaller volume than
ZNF29, is less exothermic than ZNF29 in binding RNA. We would expect the
opposite, based on our ZNF-RNA-water model explained above. This decrease
in enthalpy (less exothermic) could arise if the N terminus of ZNF29 makes a
contact with the RNA phosphate backbone while the N terminus of ZNF28 is
further from the same due to the missing methionine. The differences in enthalpy
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of ZNF28 and ZNF29 is 2.71 kcal/mol, in the range of the hydrogen bond
formation enthalpy ~ -3 to -6 kcal/mol.
The parsing of enthalpy and free energy, into a linear combination of
contributions from specific interactions, is hampered by the enthalpy - entropy
compensation observed in the binding of ZNF mutants to RREIIB. However, a
compensation between increased occupancy of water molecules in ZNF – RNA
binding (increasing the exothermic nature of the binding) and absence of side
chains (mutations) that consequently exclude interactions (decrease in the
exothermic nature of the binding) provides a rationale for the trend we see in
Figure 4.6.

c. Effect of salt pH and osmolytes on RNA binding
We have studied the effect of increasing salt conditions on the binding of
ZNF29 and ZNF29G29R to RREIIBTR. The effects of increasing salt conditions
on the their respective association constants is plotted below in Figure 4.8. We
observe, as expected, ZNF29G29R to have a higher salt dependent RREIBTR
binding compared to ZNF29. The interaction of the protein and RNA leads to
redistribution of the counterions condensed on the respective biomolecules. The
binding equilibrium by Manning’s theory (in the absence of anion release) (12)
gives the following relationship:
Log (Ka) = log Knel - m Log [M+]
where Ka is the observed association constant.
Knel is the association constant from non – electrostatic interactions.
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Figure 4.8 Effect
of salt on ZNFRREIIBTR
binding.

[M+] is the salt concentration in our case NaCl.
m is the number of Na+ counterions released on protein binding.
Manning’s condensation theory further relates the number of electrostatic
interactions with the phosphate backbone (n) to the fractional condensation (&) of
counterions bound to the backbone by the equation m =n&.
Linear fitting of the salt dependence of the ZNF29 and ZNF29G29R
indicates 1.32 and 0.82 Na+ ions being released upon protein binding. This
equation, however, ignores the release of anions from the ZNF proteins as this
polyelectrolyte model presumes the domination of cation release, assuming that
the charge density of the protein is generally considered insufficient to produce a
counterion screening of the protein. This simplification fails for small nucleic acids
and/or very basic peptides in several studies (13, 14). Both ZNF29 and
ZNF29G29R at neutral pH are highly charged with ~ 6 and ~7 positive charges,
correspond to 20 – 25 % of the amino acid content respectively. Hence the value
of m obtained for the salt dependence on binding reflects the net release of
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counterions. Even though the fractional values of counterion release seem
nonsensical, the difference in m values for ZNF29 and ZNF29G29R suggests the
interaction of the C-terminal arginine with the RNA phosphate backbone. Using
the salt dependent binding equation in Figure 4.8 (red), for ZNF29 – RREIIBTR
affinity from the gel shift assay experiment, we project the salt concentration to
be about 10 mM. This is a reasonable value when we consider sample dilution in
the well, for the gel shift experiment.
We have conducted ITC experiments in 100 mM NaF and 100 mM NaBr
for ZNF29G29r – RREIIBTR binding. We observe a decrease in the binding
affinity for NaF (Kd = 266 ± 50 nM) and NaBr (Kd = 108.4 ± 16 nM) as compared
to NaCl (Kd = 62 ± 12 nM), indicative of anion involvement in binding either
directly or by affecting the bulk water.
We have also evaluated the effects of pH on ZNF29G29R – RREIIBTR
binding at pH’s 6.25 and 8.22. Surprisingly, we observe a decrease in affinity at
both pH’s, though the affinity is affected to a higher extent at pH 6.25 (345 ± 88
nM) than pH 8.25 (139 ± 38 nM) as compared to neutral pH (Kd = 62 ± 12 nM).
We have calculated the pKa of all protonable/deprotonable groups of the protein
(Appendix B) by the program PROPKA (15) and we find that the pKa of the free
histidine His 6 and the N terminal amino group are 6.5 and 8.00 respectively.
Using these pKa values we have calculated the % of protonated His 6 and
deprotonated N terminal NH3+ in Figure 4.9 A by the Henderson-Hasselbalch
equation.

pH = pKa + log10 [A-]/[HA]
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When we compare the % protonation / deprotonation of these 2 groups to the
free energy change in the pH range 6 – 8.25, there appears to be a correlation as
shown in Figure 4.9. Currently, binding induced protonation / deprotonation of
RNA bases have not been evaluated.

A

Figure 4.9 Effect of pH on the
free energy of binding.
A. Calculated values of the %
+
deprotonation of His 6 and NH3
for ZNF29 by the HendersonHasselbalch equation.
B. Gibb’s free energy at their
respective pH.

B

To confirm proton uptake / release during binding we conducted the same
ITC experiment at pH 7.0 but in a buffer with a higher heat of ionization. The
correlation between the observed enthalpy and the proton uptake / release at a
specific pH is given by the following equation.
%Hobs = %Hint + %Hion %n
where %Hobs is the enthalpy at a certain pH.
%Hint is the intrinsic binding enthalpy that excludes enthalpy of ionization
of the buffer at that pH.
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%Hion is the enthalpy of ionization of the buffer used, from published values
(16).
%n is the net uptake or release of protons and is positive or negative
respectively.
We have used the difference in enthalpy of ionization of the buffers Phosphate
and ACES (16) at pH 7.0, 298 K to calculate %n by the following equation.
%n = (%Hobs1 - %Hobs2) / (%Hion1 - %Hion2)
From the values in the Table 4.3 below %n is calculated to be -0.16.
Table 4.3 Proton uptake/ release at pH 7.0.
Buffers

%Hobs
kcal/mol

%Hion
kcal/mol

%Hint
kcal/mol

Phosphate

-5.3 ± 0.09

1.225

-5.1 ± 0.09

ACES

-6.3 ± 0.40

7.514

-5.1 ± 0.40

%Hobs in 10 mM phosphate and ACES buffer at pH 7.0 and 298 K. %Hint has been calculated from
equations above.

This indicates a small net release of protons at pH 7.0.
The above data support the results we see for ZNF28 – RREIIBTR
binding, that the N terminal NH3+ of ZNF29, in contrast to ZNF28, is interacting
with the RNA. However, it is not clear currently how the deprotonated histidine
residue, which would leave the nitrogen with a lone pair of electrons, can interact
with the RNA.
We have also studied the involvement of water in the binding interface, in
the presence of osmolytes. Osmolytes perturb water activity and their presence
should affect the ZNF29G29R – RREIIBTR binding. The data from the osmolytes
experiments is presented in Table 4.4. We observe that with increasing concentr-
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Table 4.4 Effect of osmolyte (sucrose) on ZNF29G29R – RREIIBTR binding.
Osmolyte
concentration
osm

n

Ka
-1
M

%H
-1
kcal mol

-T % S
-1
kcal mol

ln(Ks/K0)

0

0.953

6.64E+6

-4.21

-4.59

0

0.2

0.92

6.36E+6

-5.73

-3.58

-0.043

0.6

0.921

4.02e+6

-6.67

-2.34

-0.50

1.0

0.921

4.25E+6

-6.57

-2.46

-0.45

ITC data for ZNF29G29R titration into RREIIBTR in increasing sucrose concentration at pH
7.0 and 298 K. The salt concentration (NaCl) used was 150 mM. The osmolyte
concentration is expressed in osm the osmolality of the sucrose solution. The osmolality
and molality of the solution are one and the same.

ations of sucrose, there is a decrease in binding affinity. Previous studies (17, 18)
have used the osmotic stress method successfully to study water uptake or
release in the formation of a complex and see a correlation between affinities and
the number of water molecules by the following equation.
#ln(Ks/K0)/ #[osm] = %nw/55.5 (19)
where Ks is the binding affinity at the respective osmolyte concentration.
K0 is the binding affinity in the absence of osmolytes.
[osm] is the osmolality of the solution.
%nw is the net uptake (positive value) or release (negative value) of water
molecules in the formation of the complex.
Considering only the first 3 data points (0, 0.2, 0.6), we obtain %nw ~ -26. The
negative %nw indicates a net release of water molecules bound to the free ZNF
and RNA upon complex formation. However, more data points in the osmolality
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range (0 – 0.6) have to be collected to validate the current data set. It should be
noted that future osmolyte stress experiments will be conducted with other
osmolytes, in order to verify the absence of any direct interaction of the
respective osmolyte with RNA, ZNF or the complex.

d. RNA mutants – ZNF29G29R
ITC experiments involving the binding of ZNF29G29R with the RNA
variants and mutants described in Chapter 3 are presented in the Table 4.5. All
RNA mutants bound ZNF29G29R with a 1:1 stoichiometry. Any mutations to the
G70 – C49 base pair (RREIIBTR_G70_AP, RREIIBTR_C49_U) resulted in the
lowest binding affinities. The 2-aminopurine substitutions for the guanosines in
the bulge (RREIIBTR_G48_71_2AP, RREIIBTR_G47_2AP) also resulted in
lower binding affinity, but not as drastic as changes to the G70 – C49 base pair.
Interestingly, changes to the G50 – C69 base pair (RREIIBTR_G50_AP,
RREIIBTR_C69_U) reduced affinity, but to a smaller extent, indicating mutations
at this point are not as deleterious to binding.
The imino spectra for RNA bulge mutations (RREIIBTR_G48_71_2AP,
RREIIBTR_G47_2AP) implied non-specific binding (Figure 3.10, Figure 3.11) of
ZNF29G29R. However, in the ITC data (Table 4.5) we observe that these
mutations still allow specific binding, albeit with lower affinities. The lowered
enthalpies for ZNF29G29R binding to the RNAs with bulge mutations (Figure
4.10 B and C) are likely due to lack of specific protein – RNA interactions at the
bulge.
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Table 4.5 ITC binding data for RREIIBTR mutants and variants to ZNF29G29R.
RNA

n

%G
-1
kcal mol
-9.83 ± 0.57

%H
-1
kcal mol
-5.30 ± 0.09

-T % S
-1
kcal mol
-4.52

RREIIBTR

1.0

Kd
nM
62 ± 12

RREIIBTR_G50_2AP

0.93

210 ± 32

-9.11 ± 0.11

-7.76 ± 0.20

-1.34

RREIIBTR_C69U

0.98

254 ± 49

-8.99 ± 0.15

-8.56 ± 0.33

-0.44

RREIIBTR_G70_2AP

1.0

671 ± 102

-8.42 ± 0.11

-10.14 ± 0.45

1.71

RREIIBTR_C49U

1.07

510 ± 51

-8.58 ± 0.07

-6.07 ± 0.14

-2.51

RREIIBTR_G48_71_2AP

1.04

324 ± 38

-8.85 ± 0.07

-4.67 ± 0.09

-4.17

RREIIBTR_G47_2AP

1.02

303 ± 42

-8.89 ± 0.10

-4.34 ± 0.12

-4.56

Experimental conditions were as mentioned in the legend of Table 4.1.

As evident from Figure 4.10, mutations in the middle stem (D, E, F and G) are
more exothermic and are accompanied by lower entropic contributions to the free
energy. These changes destabilize the stacking potential of the middle stem,
which in turn decreases the compact geometry of the binding site, compared to
RREIIBTR. The decrease in the binding site compactness thus results in a lower
degree of displacement of water molecules to the bulk solvent, on ZNF29G29R
binding and consequently, is manifested as higher binding enthalpies (more
exothermic, as observed in Figure 4.10 D, E, F, G) and lower binding entropies.
This effect is particularly marked when the G70 – C49 base pair is altered. This is
in agreement with the expectations of the Cooper model where lower
displacement of water from the major groove increases the enthalpic contribution
to free energy (Scheme 1).
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Figure 4.10 Graphical representation of the enthalpy, entropy and free energy of
binding for all RNA mutants and variants with ZNF29G29R.
A. RREIIBTR, B. RREIIBTR_G48_71_2AP, C. RREIIBTR_G47_2AP,
D. RREIIBTR_G50_2AP, E. RREIIBTR_C69U F. RREIIBTR_G70_2AP,
G. RREIIBTR_C49U.
The RNA sequence is displayed to the right with the position of the mutation or variation in
the middle stem (D,E,F,G) marked in red and the bulge marked in blue (B,C).

Conclusion
The parsing of the free energy of the RNA – ZNF interaction, into additive
terms, is complicated by the enthalpy - entropy compensation phenomenon
observed for the different protein and RNA mutations. We did not observe a
complete loss of binding in any of the experimental conditions or protein / RNA
mutations in our studies. Surface area models that account for the specific heat
of binding by the dehydration of nonpolar surfaces could not explain the negative
%Cp values observed. The thermodynamic binding parameters could, however,
be rationalized when we consider that the RNA – ZNF binding event involves
cooperative transitions of a multiplicity of weak interactions (regardless of the
interaction type), as suggested by Cooper (11). These interactions not only
involve the protein and the RNA but also those made with the solvent, solvent -
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solvent interactions and solvent – ion interactions. Our data implies substantial
contributions to the enthalpy of binding due to lowered displacement of solvent
and counterions from the RNA, on ZNF binding. This lowered displacement of
solvent and counterions is also evidenced as reduced entropy contributions to
the free energy of binding. An overlay of %H versus %S, for all our experiments,
display this enthalpy – entropy compensation (Figure 4.11). We note that this
linear correlation between the enthalpy and entropy is observed in both cases,
mutations in the protein or RNA (blue triangles) and under varying salt, pH,
temperature, osmolytes and buffer (red squares) conditions.
We

hypothesize

that

the

enthalpy

–

entropy

compensation

in

aforementioned cases are guided by different roles of water. In the first case,
water has a passive role (blue triangles), where mutations hamper the ability of
the respective protein or RNA to affect water displacement; while in the later (red
squares), water has an active role when experimental conditions enable its ability
to affect its displacement to the bulk solvent.
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Figure 4.11 The role of solvent in enthalpy - entropy compensation phenomenon.
%H and %S values for the binding of all ZNF mutants to RREIIBTR and the binding of
ZNF29G29R to all RNA mutants and variants are plotted with the filled blue triangle. A black
dotted line represents the linear regression fit for this data with the equation displayed in
blue.
%H and %S values for the binding of ZNF29G29R to RREIIBTR under different conditions of
salt, pH, temperature, osmolyte and buffer are plotted with the filled red square. A black
solid line represents the linear regression fit for this data with the equation displayed in red.

Note: All ITC data presented in this chapter are shown in detail in Appendix C.
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CHAPTER 5 NMR structure of RREIIBTR bound ZNF29G29R
Introduction
The structure of the RREIIBTR bound ZNF29G29R was determined from
distance and torsion angle restraints obtained from NMR data. In the current
Chapter, a brief overview of the free protein structure will be discussed, followed
by the NMR resonance assignment and structure determination of the bound
ZNF29G29R. The zinc finger chosen for the RNA – protein complex was
ZNF29G29R, since it had the highest binding affinity to RREIIBTR and is
therefore expected to be more amenable to NMR analysis in comparison to the
other RREIIBTR- mutant complexes.

Overview of free ZNF29G29R structure
The structure of the free ZNF29G29R has been previously determined (1)
using the program DYANA (1) with distance and angle restraints derived from
NMR experiments. ZNF29G29R has the characteristic !!" architecture of
Cys2His2 zinc finger proteins (Figure 5.1). The hydrophobic core of the zinc finger
is constituted by the residues Y3, C5, C10, F14, H23 and H27. The residues C5,
C10, H23, H27 are involved in zinc coordination. The amino acids Val2 – Val4
and Ser13 – Asn15 constitute the two !-strands of the antiparallel !-sheet. The !sheet is connected to a 3-turn "-helix (R17-R29) by a turn consisting of the
amino acids N15 and D16. This turn is also referred to as the “tip” of the zinc
finger.
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A

B
Y3
L20

F14
C5

H23

H27

C10
Figure 5.1 NMR solution structure of free ZNF29G29R (pdb id: 2AB7).
(A) A single representative conformer with the !!" motif has been displayed (1) with the amino
acid sidechains that constitute the hydrophobic core.
(B) An overlay of 5 structures with the lowest target function values from DYANA.

Resonance assignments for RREIIBTR bound ZNF29G29R
Structure determination by NMR requires the assignment of the spectral
resonances to their respective protons. However this process is complicated by
overlap of protein and RNA resonances, since they occur in similar chemical shift
ranges of an NMR spectrum. The issue of overlap is addressed by:
a. Isotope labeling (15N and/or

13

C) of one of the two biomolecules in this

complex, which allows detection of the proton and heteronuclear (15N
and/or 13C) chemical shifts of the labeled biomolecule by isotope edited
NMR experiments, while “filtering out” the resonances of the unlabeled
biomolecule (2).
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b. Use of 3D heteronuclear experiments which allows identification of
overlapped resonances of the labeled biomolecule, separating them by
their heteronuclear chemical shifts.
The sample used for all NMR experiments (H2O and D2O) consisted of
unlabeled RREIIBTR and

13

C,

15

N labeled ZNF29G29R. An unambiguous

assignment of the detectable protein resonances (1H,

13

C,

15

N) was obtained by

an iterative assignment process, involving all spectra listed in Table 5.1, but
generally following the order listed below.
1. 15N – 1H HSQC
A comparison of

15

N HSQC spectra (3) of free and bound ZNF29G29R

was used to identify most of the backbone amide resonances (Figure 3.27).
2. HNCA
Figure 5.2 HNCA magnetization
transfer.
The order of magnetization transfer
is denoted by 1. green, 2. red, 3.
purple and 4. blue arrows. The
coupling constants involved are:
1
1
JNH = 92 Hz, J NiCai = 11 Hz and
2
JNiCai-1 = 7Hz.
13
Spectral dimensions: F1: C, F2:
15
1
N, F3: H.

The HNCA experiment (4) correlates the alpha carbon, C" resonances of
the ith and i-1th amino acids to the backbone amide (1H and

15

N) resonances of

the ith amino acid and thus provides a sequential assignment of the protein
backbone (Figure 5.3). The magnetization transfer for HNCA is shown in Figure
5.2. The peak representing
peak from

13

13

C" (i-1) - 1Hi(i) -

C"(i) - 1HN(i) 15

15

N(i) has a higher intensity than the

N(i). A section of this sequential correlation (F7 –
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F14) of the ZNF29G29R backbone is presented in Figure 5.3. We observed
breaks in this connectivity for the regions M1 – Y3, C5 – F7, F14 – L20, and N21
– R22.

Figure 5.3 HNCA strip plot for the connectivity F7 – F14.
Each strip represents the chemical shift plane for the amino acid assigned in the box below
13
the strip. The connectivity between successive C" resonances is outlined by green lines.
The assignment process and the strip plots have been done with the aid of the NMR
assignment program SPARKY (9).
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3. HBHA(CO)NH

Figure 5.4 HBHA(CO)NH
magnetization transfer.
The order of magnetization transfer
is denoted by 1. green, 2. red, 3.
purple 4. blue and 5. grey arrows.
The coupling constants involved are:
1
1
1
JCH = 135 Hz, JCaCb = 35 Hz, J CaCo
1
1
= 55 Hz J CoiNi-1 = 15 Hz and JNH =
92 Hz. The carbonyl atom (Co) is
used as a relay and is not detected
in the experimental data (5). Spectral
1
15
1
dimensions: F1: H, F2: N, F3: H.

The HBHA(CO)NH experiment (5) correlates the backbone amide (1H and
15

N) resonances of the ith amino acid to the 1H" and 1H! resonances of the

preceeding (i-1) amino acid. The magnetization transfer for this experiment is
shown above in Figure 5.4.
4. HCCH TOCSY

Figure 5.5 HCCH TOCSY magnetization
transfer.
The order of magnetization transfer is denoted by
1. green, 2. red, and 3. purple arrows. The coupling
constants involved are:
1
1
JCH = 135 Hz, JCaCb = 35 Hz. Spectral dimensions:
1
13
1
F1: H, F2: C, F3: H.

The HCCH TOCSY experiment (6) provides a correlation for the
resonances of all carbon bound protons in the spins systems of each individual
amino acid. Furthermore, the overlap in the proton dimension is resolved by
separation of these resonances by their carbon chemical shifts. The flow of
magnetization is displayed in Figure 5.5
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5. 13C – 1H HSQC
13

A comparison of the free and bound
were used to confirm the

C HSQC spectra of ZNF29G29R

13

C" assignments as well as assign the peaks that were

not detected in the HNCA experiment. This allowed us to identify the

13

C"

resonance of M1, which was also confirmed from the HCCH TOCSY experiment.
The spectral region corresponding to the

13

C"-1H" resonances (Figure 5.6) and

the aromatic resonances of the free and bound ZNF29G29R are displayed in
Figure 5.7. As can be seen we see distinct chemical shift changes for the Met 1
(13C" and 1H") and for His6 (13C2H and 1H2H). This provides additional evidence, in
context of the ITC pH experiments in Chapter 4, of the involvement of these
residues in RREIIBTR binding.

Bound M1
Free M1

13

1

Figure 5.6 An overlay of the C" - H" spectral regions of free and bound ZNF29G29R
HSQC spectra. This overlay was created in SPARKY(9). The resonances from the bound
ZNF29G29R are in red and those from the free protein are in green. The blue dotted circle
encircles the free and the bound resonances of the amino acid M1.
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Bound H6

Free H6

Figure 5.7 An overlay of the aromatic spectral regions of free and bound
13
1
ZNF29G29R C - H HSQC spectra. This overlay was created in SPARKY(9). The
resonances from the bound ZNF29G29R are in red and those from the free protein are in
green. The blue dotted circle encircles the free and the bound resonances of the amino
acid H6.

6. HNCO
The HNCO experiment (7) correlates the backbone amide chemical shifts
(1H and

15

N) of the ith amino acid to the carbonyl (13Co) chemical shifts of the

preceding (i-1) amino acid. The flow of magnetization is depicted in Figure 5.8.

Figure 5.8 HNCO
magnetization transfer.
The order of magnetization
transfer is denoted by: 1. green,
2. red, 3. purple and 4. blue
arrows. The coupling constants
involved are:
1
1
JNH = 92 Hz, JNiCoi-1 = 15 Hz.
13
Spectral dimensions: F1: C, F2:
15
1
N, F3: H.
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All unambiguous chemical shift assignments obtained from the above
mentioned spectra are listed in Table 5.2.

Table 5.1 List of NMR experiments used for the assignment and structure
determination of the RREIIBTR bound ZNF29G29R.

Experiment

Data type

2D/3D Solvent

15

Assignment

2D H2O

13

Assignment

2D H2O/D2O

HNCA

Sequential Assignment

3D H2O

HNHA

3

3D H2O

HBHA(CO)NH

Sequential Assignment

3D H2O

HCCH TOCSY

Amino acid spin system assignment

3D H2O/D2O

N HSQC
C HSQC

JHNHA coupling constants

15

3D H2O

13

3D D2O

N NOESY HSQC NOE restraints
C NOESY HSQC NOE restraints

HNCO

Carbonyl atom assignment

3D D2O

All experiments were performed on a BRUKER Avance 500 using a 5 mM triple resonance
TM
Inverse (TXI) CryoProbe with Z-gradient. Data was processed using XWINNMR 2.5.
12
The NMR (H2O) sample (300 µl) had the following components: 0.5 mM 1:1 complex ( C,
14
13
15
N RREIIBTR – C, N ZNF29G29R), 10 mM Tris (deuterated), 100 mM NaCl, 200 µM
!me (deuterated), 25 µM ZnSO4, 10 µM NaN3, 10% D 2O, pH 7.00. The NMR (D2O) sample
12
14
13
15
(300 µl) had the following components: 0.35 mM 1:1 complex ( C, N RREIIBTR – C, N
ZNF29G29R), 10 mM Tris (deuterated), 100 mM NaCl, 200 µM !me (deuterated), 25 µM
ZnSO4, 10 µM NaN3, pH* 6.6.
Spectral referencing was done by the DSS peak at 0 ppm in a 1D spectrum. Spectral
reference values (Bruker parameter, SR) from the 1D spectrum were used in 2D and 3D
1
13
15
experiments for the H dimension. The C and N dimensions were referenced indirectly
(ref). All experiments were conducted with a relaxation delay of 1.5 s at 298 K.
NOESY experiments (H2O) were done at 2 mixing times 200 ms and 100 ms. One NOESY
experiment (D2O), was done for 150 ms.

Table 5.2 Chemical shift assignment table from SPARKY.
CA

CO

HA

HB2

HB3

HD2

HD21

HN

N

ND2

QB

QD

QE

QG

QG1

QG2

QQD

MET1

54.63

-

4.078

-

-

-

-

-

-

-

2.04

-

-

2.417

-

-

-

VAL2

61.24

174.4

4.396

1.86

-

-

-

-

-

-

-

-

-

-

0.8042

-

-

TYR3

57.36

174.7

4.603

3.029

2.676

-

-

8.916

124.9

-

-

6.965

6.813

-

-

-

-

VAL4

61.03

174.7

4.567

1.66

-

-

-

8.535

124.2

-

-

-

-

-

0.5399

0.7913

-

CYS5

60.53

-

4.367

3.431

-

-

-

8.917

128.3

-

-

-

-

-

-

-

-

HIS6

55.74

175.1

4.871

3.521

3.162

7.287

-

-

-

-

-

-

-

-

-

-

-

PHE7

60.18

175.5

4.042

2.643

2.239

-

-

8.596

125.7

-

-

6.971

7.279

-

-

-

-

GLU8

58.02

176.2

3.757

-

-

-

-

8.141

128.2

-

1.70

-

-

1.941

-

-

-

ASN9

54.39

174.1

4.371

3.109

2.938

-

7.681

8.761

116.8

113.1

-

-

-

-

-

-

-

CYS10

61.09

176.2

4.587

3.132

2.999

-

-

8.079

121.6

-

-

-

-

-

-

-

-

GLY11

45.79

174.7

4.002

-

-

-

-

8.205

105.7

-

-

-

-

-

-

-

-

ARG12

57.19

174.1

3.989

1.373

-

-

-

8.128

122.1

-

-

-

-

3.063

-

-

-

SER13

56.53

172.9

5.219

-

-

-

-

7.827

114.4

-

3.54

-

-

-

-

-

-

PHE14

57.05

175.5

4.792

2.72

3.261

-

-

8.941

118.6

-

-

7.229

6.925

-

-

-

-

ASN15

53.31

174.7

5.251

-

-

-

6.973

9.354

-

113

3.03

-

-

-

-

-

-

ASP16

53.07

-

4.757

2.814

2.647

-

-

7.312

115.4

-

-

-

-

-

-

-

-

ARG17

58.76

-

3.11

-

-

-

-

-

-

-

1.23

-

-

-

-

-

-

ARG18

59.03

180.2

3.921

-

-

-

-

8.296

120.1

-

1.76

-

-

-

-

-

-

LYS19

-

179.4

-

-

-

-

-

7.803

119.2

-

-

-

-

-

-

-

-

LEU20

-

177.5

3.123

-

-

-

-

6.967

121.4

-

1.86

-

-

-

-

-

0.9952

ASN21

56.5

177.8

4.186

-

-

-

-

8.268

118.4

-

2.74

-

-

-

-

-

-

ARG22

59.23

178.6

3.955

-

-

-

-

7.723

119.4

-

1.78

3.073

-

1.574

-

-

-

HIS23

58.6

176.3

4.203

3.064

2.868

-

-

7.458

119.5

-

-

-

-

-

-

-

-

LYS24

60.01

178

3.522

-

-

-

-

8.288

115.9

-

-

1.866

-

-

-

-

-

LYS25

58.44

178.8

3.978

-

-

-

-

6.94

117

-

1.46

1.808

2.94

1.67

-

-

-

ILE26

63.11

177.3

3.89

1.692

-

-

-

7.824

116

-

-

0.59

-

-

0.8505

-

-

HIS27

54.84

175.3

4.402

1.949

2.494

6.354

-

7.008

117

-

-

-

-

-

-

-

-

THR28

61.57

173.5

4.362

4.328

-

-

-

7.475

111.8

-

-

-

-

-

-

1.186

-

ARG29

57.72

-

4.182

-

-

-

-

7.652

128.1

-

1.79

-

-

1.667

-

-

-

The atom names used are as in the dyana.lib file atom definitions (10). Pseudo atom names are used when stereospecific
assignments could not be made or when diastereotopic groups were overlapped. Pseudo atom names start with the letter Q for
!,",# protons and with QQ for methyl groups.
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Backbone chemical shift differences between free and bound ZNF29G29R
Chemical shift differences of the protein backbone between the free and
RREIIBTR bound ZNF29G29R are displayed in Figures 5.9, 5.10, 5.11, 5.12 and
5.13. As can be seen, other than M1 and H6, most of changes generally
occurred in the !-helix spanning R17-R29. The residue F14 showed the largest
difference in carbonyl chemical shift. The residues missing assignments are
indicated by black filled triangles.
The backbone torsion angle " is defined by the atoms 1HN,
1

H! while the backbone torsion angle # includes the atoms 1H!,

13

15

C!,

N,

13

13

C! and

Co and O.

The chemical shift difference data for these atoms thus allows us to use coupling
constants of the free protein, in the structure determination of the RREIIBTR
bound ZNF29G29R, for the residues which show minimal differences (within
dashed lines) for all 5 atoms (1HN,
“minimal differences” were:
±0.05 ppm and

13

15

N,

13

C!, 1H! and

13

Co). The criteria used for

C! ±0.1 ppm, 1H! ±0.05 ppm,

15

N ±0.1 ppm, 1HN

13

Co ±0.2 ppm. The above criteria were based on the ppm

tolerances allowed in chemical shift assignments, of the same nuclei, in different
spectra of the same sample. The residues which meet the above-mentioned
criteria, for all 5 atoms constituting the backbone torsion angles, are C5, E8, N9,
G11, R12, S13 and L20. These coupling constants are in addition to those
derived from the HNHA experiment. For residues which had coupling constant
inputs from the chemical shift difference Table as well as the HNHA experiment,
we used the values derived from the HNHA experiment, as described below.
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13

C!

Figure 5.9 Chemical shift differences (bound – free) for

1

13

C! resonances (ppm).

H!

1

Figure 5.10 Chemical shift differences (bound – free) for H! resonances (ppm).
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15

N

Figure 5.11 Chemical shift differences (bound – free) for
resonances (ppm).

1

15

N (backbone amide)

HN

1

Figure 5.12 Chemical shift differences for (bound – free) H N (backbone amide)
resonances (ppm).
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13

C’

Figure 5.13 Chemical shift differences (bound – free) for
(ppm).

13

C’ (carbonyl) resonances

Coupling constants for the torsion angle ": HNHA
The HNHA experiment is a 3D NMR experiment that facilitates the
determination of the three-bond 1HN-1H! J-coupling constants (8). The diagonal
peak in a HNHA experiment represents the backbone amide resonances (1HN,
15

N) while the cross-peak represents the 1H! resonance. The diagonal peak and

its corresponding cross-peak have opposite phases. The intensity ratio between
the cross-peak and the diagonal peak provides a direct measure of the
magnitude of 3J(1HN-1H!) by the following equation (8).
Intensity(cross peak) / Intensity(diagonal peak) = -tan2(2#JHH$)
where JHH is the 3 bond coupling constant 3J(1HN-1H!) in Hz,
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2$ is the delay after the initial 90° proton pulse during which the transverse
1

HN magnetization dephases as a result of the homonuclear 1HN-1H!

scalar coupling. In our HNHA experiment $=13.5 ms.
The antiphase magnetization component of the cross-peak relaxes at a faster
rate than the inphase magnetization of the diagonal peak. The equation above
has been derived with the assumption that both, inphase and antiphase,
magnetizations relax at identical rates. This discrepancy is addressed by a 11%
correction to the coupling constant values obtained by the equation mentioned
above (8). The determination of 3J(1HN-1H!) coupling constant is complicated by
their small size relative to natural proton line widths and hence coupling
constants for all residues could not be achieved by this method, for the RNA
bound ZNF29G29R. The intensities of the diagonal and cross-peaks were
determined using the SPARKY NMR assignment program (9). The coupling
constants derived from the HNHA data as well as those supplemented from the
chemical shift difference data is listed in Table 5.3.
Table 5.3 Coupling constants from the HNHA experiment.
Residue
Y3
C5*
E8*
N9
C10
G11
R12*
S13
L20*
H27
T28

3

J(HN-HA) (Hz)
9.92
8.4
4.88
7.20
7.20
7.05
5.70
8.42
4.88
7.67
8.73

The intensities of cross-peaks and diagonal peaks were
extracted by SPARKY. The amino acids marked by * indicate
unchanged chemical shift for the bound ZNF from the free
protein and had inputs from the free ZNF29G29R coupling
constants (1).
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Distance restraints: NOESY
Distance restraints for structure determination in NMR are obtained by the
integration of the cross-peak volumes of assigned peaks in a NOESY spectrum.
The NOESY experiment detects the alteration in the resonance intensities of
nuclei in close proximity (< 5 Å) due to the Nuclear Overhauser Effect (NOE).
This NOE effect is manifested in cross-peaks that correlate the distance between
the corresponding resonances (1H) by their intensity. The NOESY cross-peak
volume is proportional to r-6, where r is the distance between those protons.
The determination of distance restraints for the RREIIBTR bound
ZNF29G29R has been carried out by the 3D experiments: 1H-15N NOESY-HSQC
for H2O samples and 1H-13C NOESY-HSQC for D2O samples. The first part of the
experiment detects the NOE between 2 protons while the second part detects
15

N-attached protons only, thus effectively screening out the intra-RREIIBTR

(unlabeled) NOE cross-peaks. As a result, the volume of the cross-peaks in this
spectrum represent intramolecular NOE’s (15N labeled ZNF29G29R) and
intermolecular NOE’s (unlabeled RREIIBTR -

15

N labeled ZNF29G29R). The 1H-

13

C NOESY-HSQC experiment works in the same manner except NOE cross-

peaks are detected to 13C attached protons.
The 3D NOESY HSQC experiments for the complex in H2O and D2O were
carried out with mixing times of 200 and 150 ms respectively. The assignments
of the cross-peaks were achieved from previously assigned spectra (Table 5.1,
Table 5.2). Since RNA resonance assignments are not known currently, some
cross-peaks could not be assigned unambiguously. The integration of cross peak
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volumes were carried out in the NMR assignment program SPARKY. Cross-peak
volumes were then converted to approximate distances (upper distance limits) by
the CALIBA macro in the structure calculation program DYANA (10). The above
cross-peak volume to upper distance restraint conversion is explained in detail in
the following section.

Structure calculation and analysis
There are several methods that are used to perform structural calculations
from NMR data. Some of the most widely used algorithms include metric matrix
distance geometry, variable target function method, molecular dynamics in
cartesian space and torsion angle dynamics. All these methods search
conformational space to satisfy the NMR derived restraints. Amongst these,
torsion angle dynamics (TAD) provides one of the most efficient ways to
calculate NMR structure of biomolecules (10). TAD searches torsion angle space
to fulfill conformational restraints by conjugate gradient minimization of a variable
target function. The target function involves the potential energy of the system. In
addition, TAD uses simulated annealing combined with molecular dynamics so
that the target function does not get trapped in local minima. Simulated annealing
consists of heating the system in silico to a high temperature and then cooling it
down slowly, in order to cross barriers between local minima of the target
function.
We have used the structural calculation program DYANA (Dynamics
algorithm for NMR applications) (10), which incorporates TAD with simulated
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annealing for the calculation of macromolecular structures from the restraints
derived from NMR data. The initial inputs to the program consisted of 181
integrated cross-peak volumes (NOESY) and 11 coupling constants (HNHA).
The cross-peak volumes are calibrated by a DYANA macro called CALIBA.
CALIBA calibrated the volumes using 3 different calibration classes, V= A/r6 for
backbone protons, V= B/r4 for flexible side chain protons, and V= C/r4 for methyl
groups, where V is the volume of the cross peak and r is the corresponding
distance. The parameters A, B and C were calculated automatically by CALIBA
based on the NMR data. These distances (Å) were written to an upper distance
limits (upl) file. In addition to the above mentioned upper distance limits from
NMR data, upper distance limits for Zn2+ coordination to the residues C5, C10,
H23, H27 were also included in the upl file. A lower distance limits (lol) file was
also created that included the lower distance constraints for Zn2+ coordination to
the residues C5, C10, H23, H27. These values for Zn2+ coordination restraints
were obtained from literature (1, 11, 12, 13). The lol file was further appended
with lower distance limits for restraints that were calculated to be above 4 Å by
CALIBA, by subtracting 2 Å from upper distance constraints. The scalar coupling
constants obtained from the HNHA experiment and from chemical shift difference
data mentioned before, were written into a coupling constant file (cco). These 3
files (upl, lol, cco) are then utilized by the DYANA macro GRIDSEARCH for a
systematic analysis of local conformations around the C! atom of each residue to
determine allowed conformations for the dihedral angles ", %, &1 and &2. The
macro HABAS was then used to stereospecifically assign diastereotopic groups
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of the sidechains and write these constraints to an angle constraint file (aco). The
initial aco file created consisted of 88 dihedral angle constraints.
Initial structures were calculated with the upl, lol and aco data by the
DYANA macro ANNEAL from random conformations. ANNEAL was used to
perform simulated annealing cycle with a total of 6000 TAD steps in the following
order (10, 14).
1. An initial 100 step minimization cycle to reduce high energy interactions
that would otherwise perturb the TAD algorithm.
2. 1200 TAD steps at a constant high temperature, 10,000 K.
3. 4800 TAD calculations with slow cooling to 0 K.
4. Inclusion of H atoms to check for steric overlap and a 100 step conjugate
gradient minimization cycle. This was followed by 200 TAD steps at 0 K.
The H atoms were excluded till step 4 and check for steric overlap was
only performed for heavy atoms.
5. A final 1000-step conjugate gradient minimization cycle.
We calculated the initial 50 conformers in this manner. After this structure
calculation, an overview file sorts the structures in ascending order of target
function values (f). The target function value is indicative of the agreement
between the conformers generated by DYANA and NMR restraints applied. The
overview file also contained the root mean square deviation (RMSD) for the
backbone atoms and heavy atoms for the conformers along with distance and
angle violations. These violations were remedied by confirming the assignment
and the integration of the respective cross peaks. If the assignment could not be
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faulted, the corresponding distance violation was incremented by 1 Å and 50 new
conformers were generated from the updated upl and the older lol and aco files.
The above-mentioned correction for upper distance limits were performed only
for violations that showed up in all conformers and for overlapped cross-peaks.
This process of updating the upl file was performed until the 50 conformers
generated had 0 violations.
The quality of NMR structure calculations depend on the percentage of all
conformers calculated that reach target function values below 1 Å2. The
percentage

of

initial

ensemble

of

conformers

calculated

without

any

distance/angle violations that had target function values below 1 Å2 was low ~
20%. This percentage was improved by using the REDAC strategy (14). The
REDAC strategy produces additional angle constraints by first calculating an
ensemble of 50 structures with the variable target function method and then
generating redundant angle constraints for all residues with local target function
values below the ang_cut parameter (0.2º) (14). The new aco file (with the
additional REDAC generated angle constraints) was then used to calculate a set
of 50 conformers and the percentage of target function values and RMSD values
were evaluated. The REDAC strategy, followed by calculation of conformers, was
carried out untill no significant improvement in the percentage of target function
values below 1 Å2, reduction in the RMSD values and increase in the number of
angle constraints were observed. The final cycle of REDAC resulted in a total of
112 angle constraints. A flowchart of the entire structure determination process is
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presented in Figure 5.14. The results (overview) of the final set of 30 conformers,
out of the total 50 calculated, are displayed in Table 5.4.
The type (sequential, medium, long range) and the distribution of
restraints used to calculate this ensemble, along the ZNF29G29R sequence is
displayed in the Figures 5.17 and 5.18. A Ramachandran plot of " and %
distributions for all 30 conformers displayed in Figure 5.15 indicate that most "
and % angles for this set of conformers lie in allowed regions. Finally, an overlay
of the 30 conformers is presented in Figure 5.19.
The ensemble of conformers in Figure 5.19 represents a set of preliminary
structures in the structure determination process and needs further refinement.
Nevertheless, the tertiary features of the structure are already emerging. The
elements of the structure involving residues V2 - D16, in these conformers. are
more converged than for residues R17 - R29 (Figure 5.19). This is perhaps not
surprising since the number of constraints for the former greatly outnumber the
latter (Figure 5.17). A set of 30 conformers calculated without the zinc upper and
lower restraints also resulted in a similar bundle of structures, albeit with lower
target function values (average target function values for 30 out of 50
conformers: 0.65). This demonstrates that the structure calculation process was
not biased by zinc restraints.
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Figure 5.14 Flowchart of the structure determination process.
The blue dashed box indicates functions performed in SPARKY (9)

Final constraints used in structure determination
A summary of the final constraints used and final structures calculated are
listed below.
NOE derived upper distance constraints (upl)
Dihedral angle constraints (aco)
Zn2+ coordination distance constraints
upper (upl)
lower (lol)
Total constraints
Total number of conformers calculated
Percentage of conformers calculated with
target function values < 1 Å2
Final number of conformers written to pdb
Number of conformers with violations
distance violations > 0.2 Å
angle violations > 0.1º

163
112
4
4
283
50
54
30
0
0
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Table 5.4 Overview of the final 30 conformers.
Structural statistics:
str target
upper limits lower limits van der Waals torsion angles
function
# sum max # sum max # sum max # sum max
1 4.32E-02
0 0.6 0.11 0 0.0 0.00 0 0.3 0.04 0 0.0 0.00
2 5.88E-02
0 0.7 0.11 0 0.0 0.00 0 0.2 0.04 0 0.0 0.00
3 6.70E-02
0 0.7 0.14 0 0.0 0.00 0 0.3 0.04 0 0.0 0.01
4 9.16E-02
0 0.7 0.14 0 0.0 0.00 0 0.5 0.05 0 0.0 0.01
5
0.13
0 1.1 0.11 0 0.1 0.07 0 0.5 0.11 0 0.0 0.02
6
0.15
0 0.8 0.17 0 0.2 0.07 0 0.6 0.07 0 0.2 0.05
7
0.15
0 1.2 0.10 1 0.2 0.21 0 0.5 0.06 0 0.1 0.04
8
0.16
1 0.9 0.25 0 0.0 0.02 0 0.6 0.09 0 0.0 0.01
9
0.18
0 1.1 0.16 0 0.0 0.02 0 0.7 0.12 0 0.1 0.05
10
0.18
0 1.1 0.14 0 0.0 0.05 0 0.9 0.08 0 0.1 0.04
11
0.23
0 1.2 0.19 0 0.2 0.17 0 0.7 0.16 0 0.0 0.01
12
0.29
0 1.2 0.15 1 0.4 0.20 0 1.1 0.11 0 0.1 0.05
13
0.29
0 1.4 0.17 1 0.4 0.23 0 1.0 0.12 0 0.0 0.01
14
0.36
1 1.3 0.26 0 0.0 0.01 1 0.9 0.27 0 0.1 0.04
15
0.44
3 1.7 0.38 0 0.0 0.01 0 0.6 0.12 0 0.0 0.01
16
0.44
1 2.0 0.28 0 0.2 0.07 0 1.3 0.17 0 0.2 0.04
17
0.44
0 1.9 0.16 0 0.0 0.03 0 1.9 0.15 0 0.2 0.08
18
0.47
3 1.5 0.39 0 0.0 0.01 0 0.9 0.13 0 0.0 0.00
19
0.53
1 1.6 0.22 1 0.4 0.21 0 1.7 0.15 0 0.0 0.01
20
0.53
4 2.0 0.28 0 0.1 0.06 1 1.1 0.22 0 0.2 0.05
21
0.57
0 2.2 0.20 0 0.3 0.13 1 2.0 0.21 0 0.1 0.05
22
0.58
1 2.2 0.28 2 0.6 0.28 0 1.8 0.10 0 0.1 0.08
23
0.63
2 2.3 0.26 1 0.7 0.21 0 1.4 0.15 0 0.2 0.05
24
0.84
1 2.3 0.25 0 0.0 0.00 1 2.4 0.32 0 0.2 0.11
25
0.90
4 2.8 0.46 0 0.1 0.08 0 1.3 0.15 0 0.2 0.07
26
0.94
4 3.2 0.27 0 0.3 0.18 1 2.2 0.26 0 0.2 0.08
27
0.95
3 3.2 0.27 1 0.5 0.27 0 2.4 0.19 0 0.2 0.07
28
1.06
6 3.6 0.27 2 0.7 0.29 0 2.0 0.18 0 0.2 0.08
29
1.09
3 3.1 0.42 2 0.6 0.24 1 1.7 0.20 0 0.1 0.09
30
1.10
4 3.5 0.29 0 0.0 0.02 2 2.3 0.29 0 0.3 0.09
Ave
0.46
1 1.8 0.23 0 0.2 0.10 0 1.2 0.14 0 0.1 0.04
+/0.33
2 0.9 0.09 1 0.2 0.10 1 0.7 0.07 0 0.1 0.03
Min 4.32E-02
0 0.6 0.10 0 0.0 0.00 0 0.2 0.04 0 0.0 0.00
Max
1.10
6 3.6 0.46 2 0.7 0.29 2 2.4 0.32 0 0.3 0.11
Constraints violated in 10 or more structures:
# mean max. 1 5 10 15 20 25 30
0 violated distance constraints.
0 violated angle constraints.
Pairwise RMSDs for residues 1..45:
Mean global backbone RMSD: 4.31 +/- 0.82 A (2.23..6.56 A)
Mean global heavy atom RMSD: 4.53 +/- 0.92 A (1.86..6.37 A)
50 conformeers were calculated and an overview of 30 conformers with the
lowest target function values are presented. This overview file was generated by
DYANA (10).
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Figure 5.15 Ramachandran
plot for the calculated
ensemble of structures.
Each circle corresponds to ", %
values of a non-glycine residue
in all 30 conformers presented
in table 5.4. The regions are
colored from darker to lighter
shades of blue to represent
most favorable, additionally
favorable
and
generously
allowed respectively. The white
regions represent disallowed
regions.
This
plot
was
generated by the program
DYANA (10).

Figure 5.16 Angle and distance constraints used in structure calculations.
For ", % a triangle pointing upward indicate torsion angle restraints for ideal !-helix
and 310 helix while a triangle pointing downward represents ideal parallel or
antiparallel '-strand torsion angle restraints. A star indicates conformation of both !
and ' secondary structure types. A circle marks restraints that exclude torsion angle
values of regular secondary structure elements. For &, squares of decreasing sizes
indicate allowances for 1, 2 or all 3 of the staggered rotamer positions. Filled circles in
& indicate exclusion of all 3 staggered rotamer positions. Upper distance limits
(sequential, medium-range) are shown by horizontal lines connecting the residues
involved. The thickness of the lines for sequential distances are inversely proportional
to the squared upper distance bound. This plot was generated by the program
DYANA (10).

115

Figure 5.17 Distribution of constraints used in structure calculations.
This plot was generated by the program DYANA (10).

Figure 5.18 Number of constraints for each amino acid residue.
Intraresidue: white, sequential: light grey, medium-range (i-j < 5): dark grey, long
range (i-j > 5): black. This plot was generated by the program DYANA (10).
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Figure 5.19 Ensemble of the 30 lowest target function value structures calculated by
DYANA. (A and B) Different views of the backbone overlay of 30 lowest target function value
conformers in wire frame. (C and D) Representations of A and B in sausage format. Both
graphical representations were generated by the program MolMol (16).

The following inputs to the structure calculation process will further aid in
the refinement of the structures:
a. Quantitative NOE’s
The calibration of the NOESY cross-peak volumes by CALIBA does not account
for spin diffusion and hence are expressed as allowed ranges and not specific
distances. Spin diffusion is a result of higher mixing times when the NOE
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enhancement between 2 protons start perturbing the intensities of other
neighboring protons. As a consequence, the cross-peak volumes are not
representative of the true distance between these protons. The use of relaxation
matrix methods, which take spin diffusion into account, will allow for the
extraction of more narrow and precise distance ranges.
b. Additional torsion restraints
The program TALOS (15) will be used to generate additional torsion restraints
based on the chemical shift data collected.
c. Dipolar restraints
The residual dipolar coupling data, which can be extracted by orientation of the
complex in stronger magnetic fields, yields directional restraints for the
and

13

C - 1H

15

N - 1H bond vectors. Inclusion of these restraints in the calculation process

will result in a much tighter bundle of structures generated.
d. Structure calculation for the complex
The structure determination for the complex will greatly reduce the
conformational space for the calculation of the bound ZNF29G29R structure. As
a result, the ensemble of structures for the bound protein will have a higher
convergence of their backbone traces as well as sidechains.

Conclusion
The bundle of conformers presented as the preliminary structures of the
RREIIBTR bound ZNF29G29R have acceptable values of target function values
and have no violations for the experimental constraints imposed. The quality of

118
the structures, in terms of the convergence of the ensemble, will be improved by
refinement strategies mentioned earlier. The structure determination process did
not have a bias towards any desirable features in the conformation and was
mainly driven by distance restraints. This is supported by the fact that structure
calculations in the absence of either lower limits, zinc restraints or angle
constraints generated by the REDAC strategy, still produced ensembles that had
similar tertiary structural features. Thus this process was mainly driven by
distance restraints.
The RMSD values for the current set of conformers calculated with all
restraints is higher, but is not a true measure of the quality of the structure, since
some regions of the bound zinc finger may be genuinely mobile. These regions,
especially N15 – K19, may not show convergence even in the ensembles
calculated with further refinements, if experimental distance restraints cannot be
imposed. The internal mobility of these regions lends them larger linewidths and
lower intensities due to chemical exchange equilibrium between multiple
magnetic environments. The above-mentioned increase in peak linewidth is in
addition to contributions from transverse spin-spin relaxation (linewidth at half
peak height is inversely proportional to T2, the transverse spin-spin relaxation
time). As a result, NOE cross-peaks between two nuclei might be absent in
NOESY experiments even though they are within 5 Å of each other. Internal
motions also influence the correlation times, which in turn lead to errors in
distance constraints for detectable cross-peaks. In order to access whether the
non-convergence of the ensemble over a particular region of the protein structure
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is either due to the absence of restraints or due to internal motions,

13

C and

15

N

(backbone) relaxation rates for the bound ZNF29G29R will be determined.
Additionally, model free analyses can be used to obtain information about the
site-specific internal dynamics of the bound ZNF (17). The analysis is called
model free since the parameters derived are independent of any specific model
for internal motion. The NMR relaxation rates R1 (spin – lattice), R2 (spin – spin)
and heteronuclear NOE’s (13C – 1H,

15

N – 1H) are sensitive to internal motions in

the subnanosecond timescales and will be determined for the bound ZNF. These
rates will then be used to obtain the order parameters (S2) and correlation times
((e) to characterize the internal motions of the backbone bond vectors (15N – 1HN,
13

C! – 1H!) in the protein sequence (17). The order parameters (S2) are closer to

1 for rigid bonds or closer to 0 for isotropic motions and provide information
regarding the angular amplitude of internal motion of these bond vectors.
Nevertheless, the current conformers as well as NMR data provide
reasonable commentary on the bound ZNF29G29R in terms of the tertiary
structure, secondary structural elements as well as the hydrophobic core, as
detailed below:
1. The tertiary structural fold of the bound zinc finger is similar to the free zinc
finger, consisting of 2 strands (M1 - H6, C10 - F14) connected to a helical
element (R18 – R29). These 2 strands are connected by a turn constituted by the
residues F7 – N9, and represent a '-sheet like element, which is connected to
the helical element by another turn (N15 – R17). The ", % angles calculated for
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the conformers currently does not allow us to strictly define these elements in
terms of '-sheet, ! / 310 helix or type I / II turns.
2. The hydrophobic core geometry in the bound ZNF29G29R as well as zinc
coordination is very similar to that in the free zinc finger, consisting of C5, C10,
F14, L20, H23 and H27. The following evidence confirms the above statement.
a. The chemical shifts for the H23 and H27 ring protons do not change in
the bound protein. The H27 2H proton is shifted upfield due to ring current
effects of the H23 stacked above it. Since the local magnetic environment
effects chemical shifts, and the H27 2H proton chemical shift is
unchanged, H33 and H27 maintain their geometry in the bound form of the
ZNF. This can be evidenced more clearly in the overlay of the aromatic
spectral region of the 2D HSQC (13C 1H) spectrum of the free and bound
protein (Figure 5.7). Furthermore, since the positioning of H23 and H27 in
the hydrophobic core is due to zinc coordination and the backbone
chemical shifts of C5 and C10 are almost unchanged in the bound
ZNF29G29R, we can conclude that the zinc coordination geometry in
the bound ZNF is the same as the free ZNF.
b. The overlay (Figure 5.7) also shows the upfield shifted 4H resonance of
F14, which is also a result of ring current effects of H23, since F14 4H
is positioned directly above it. Hence the large chemical shift
difference observed for the F14 (Figure 5.13) carbonyl atom may reflect
changes to the N15 posturing in the bound ZNF29G29R.
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c. NOE cross-peaks for L20 - F14 and L20 - H23 sidechains are observed
in the NOESY spectrum and have been used in the distance constraints
applied for structure calculation.
The only difference is the absence of Y3, for which NOE cross-peaks to other
residues mentioned above could not be assigned unambiguously in the NOESY
spectrum of the bound ZNF.
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Summation
The ''! framework of zinc finger proteins has served as a stable
framework for design of novel RNA binding proteins (1, 2). The protein,
ZNF29G29R, currently the ZNF with the highest affinity for RREIIBTR, has
shown similar consistency, as evidenced by studies presented in this
dissertation. The original 2-zinc finger construct that was designed by phage
display to target RREIIB, has been shown to function in an in vivo context by
LTR-CAT assays (1). It was also shown, that a major contribution to the binding
interaction was from the 2nd zinc finger in that construct (3), a slightly longer
version of ZNF29. It stands to reason that both ZNF29 and ZNF29G29R should
also function efficiently in targeting RREIIB specifically, within in vivo
environments. In addition, the compact architecture of a single ZNF will have its
advantages as it is sufficiently small to enter the nucleus by diffusion. The current
binding affinity of ZNF29G29R, despite improvement over its ZNF29 parent, is
not as efficient as the monomeric Rev protein (3). However, thermodynamic
binding studies of the ZNF29 mutants, especially ZNF29N21Q have shown
promises in further increasing the binding affinity.
The thermodynamic ITC studies of these mutants display trends that could
be explained by Dr. Alan Cooper’s models (4). The determination of the specific
heat of binding of ZNF29 to RREIIBTR will provide further confirmation of this
model. We expect the specific heat of binding for ZNF29 – RREIIBTR to be
higher (more negative) than that of ZNF29G29R – RREIIBTR, as predicted by
this model (4). Also, preparations are currently ongoing to study the free energy
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of binding, of the mutant ZNF29H6A in the pH range 6.5 – 8.25, by ITC. We
expect the free energy of binding of this mutant to vary linearly over this pH
range, since it lacks the H6 residue.
We are also in the process of producing isotope labeled RREIIBTR, which
will allow us to assign unambiguously the identity of the new imino proton peaks
on ZNF binding. Furthermore, the use of isotope edited NMR experimental data
(5) from complex samples containing

13

C

15

N RREIIBTR and unlabeled

ZNF29G29R will be used in the structure determination of the bound RREIIBTR
and finally the complex.
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APPENDIX A: Site directed mutagenesis primers

ZNF29 Protein sequence:
MVYVCHFENCGRSFNDRRKLNRHKKIHTR

ZNF29 DNA sequence:
Forward sequence
5’ ATG GTC TAT GTG TGT CAC TTT GAA AAT TGC GGC CGT AGC TTC AAT
GAT CGT CGT AAA TTG AAT CGT CAC AAA AAA ATT CAC ACC CGT 3’
Reverse sequence
5 ‘ ACG GGT GTG AAT TTT TTT GTG ACG ATT CAA TTT ACG ACG ATC ATT
GAA GCT ACG GCC GCA ATT TTC AAA GTG ACA CAC ATA GAC CAT 3’

1. ZNF29H6A primers
Forward primer
5’ GCC GCA ATT TTC AAA AGC ACA CAC ATA GAC CAT 3’
Reverse primer
5’ ATG GTC TAT GTG TGT GCT TTT GAA AAT TGC GGC 3’

2. ZNF29H6K
Forward primer
5’ GCC GCA ATT TTC AAA TTT ACA CAC ATA GAC CAT 3’
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Reverse primer
5’ ATG GTC TAT GTG TGT AAA TTT GAA AAT TGC GGC 3’

3. ZNF29N15A
Forward primer
5'- ATT CAA TTT ACG ACG ATC AGC GAA GCT ACG GCC -3'
Reverse primer
5'- GGC CGT AGC TTC GCT GAT CGT CGT AAA TTG AAT -3'

ZNF29D16A:
Forward primer
5’ ATT CAA TTT ACG ACG AGC ATT GAA GCT ACG GCC 3’
Reverse primer
5’ GGC CGT AGC TTC AAT GCT CGT CGT AAA TTG AAT 3’

The yellow highlighted triplets indicate the mutated amino acid.
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APPENDIX B: PROPKA Amino acid sidechain predictions
a. ZNF29
RESIDUE
ASP 16A
GLU
8A
C29A
HIS
6A
HIS 23A
HIS 27A
CYS
5A
CYS 10A
TYR
3A
N+
1A
LYS 19A
LYS 24A
LYS 25A
ARG 12A
ARG 17A
ARG 18A
ARG 22A

pKa
2.70
4.50
3.30
6.50
9.17
9.67
4.64
4.48
10.00
7.86
10.50
10.01
10.50
12.43
12.43
12.43
12.50

b. ZNF29G29R
RESIDUE
ASP 16A
GLU
8A
C29A
HIS
6A
HIS 23A
HIS 27A
CYS
5A
CYS 10A
TYR
3A
N+
1A
LYS 19A
LYS 24A
LYS 25A
ARG 12A
ARG 17A
ARG 18A
ARG 22A
ARG 29A

pKa
3.31
4.50
3.34
6.50
9.49
9.55
4.98
2.13
9.65
7.72
10.29
10.50
10.50
12.50
12.22
12.50
12.50
12.50

pKmodel
3.80
4.50
3.20
6.50
6.50
6.50
9.00
9.00
10.00
8.00
10.50
10.50
10.50
12.50
12.50
12.50
12.50
pKmodel
3.80
4.50
3.20
6.50
6.50
6.50
9.00
9.00
10.00
8.00
10.50
10.50
10.50
12.50
12.50
12.50
12.50
12.50

The input files were 2AB3 and 2AB7 for ZNF29 and ZNF29G29R for the web
interface of the program PROPKA (http://propka.ki.ku.dk/~drogers/).

APPENDIX C: ITC Thermodynamics Data
Protein

RNA

Changed
Condition *

Changed
values *

n

Ka
-1
M

!H
-1
cal mol

!S
-1 -1
cal mol K

ZNF29

RREIIBTR

0.966 ± 0.015

5.89E+06 ± 6.71E+05

-7609 ± 137

5.40

ZNF29G29R

RREIIBTR

1.001 ± 0.004

1.62E+07 ± 3.09E+06

-5298 ± 92

15.18

ZNF29H6A

RREIIBTR

0.991 ± 0.021

4.51E+06 ± 6.72e+05

-5401 ± 135

12.33

ZNF29H6K

RREIIBTR

1.010 ± 0.017

1.05E+07 ± 2.48E+06

-4299 ± 102

17.70

ZNF29R12A

RREIIBTR

0.991 ± 0.020

1.86E+06 ± 2.92E+05

-6502 ± 311

6.84

ZNF29N15A

RREIIBTR

1.035 ± 0.015

3.69E+06 ± 5.21E+05

-7626 ± 177

4.45

ZNF29D16A

RREIIBTR

0.984 ± 0.015

2.61E+06 ± 2.61E+05

-7829 ± 154

3.08

ZNF29N21A

RREIIBTR

0.980 ± 0.017

4.31E+06 ± 6.36E+05

-6649 ± 156

8.06

ZNF29N21Q

RREIIBTR

0.952 ± 0.015

1.23E+07 ± 3.53E+06

-7712 ± 217

6.58

ZNF28

RREIIBTR

0.982 ± 0.016

5.80E+06 ± 2.03E+06

-4895 ± 164

14.20

ZNF29G29R

RREIIBTR _G50_2AP

0.930 ± 0.019

4.77E+06 ± 8.56E+05

-7762 ± 206

4.52

ZNF29G29R

RREIIBTR _G70_2AP

1.000 ± 0.033

1.49E+06 ± 2.67E+05

-10140 ± 454

-5.75

ZNF29G29R

RREIIBTR_G48_71_2AP

1.040 ± 0.016

3.09E+06 ± 3.88E+05

-4674 ± 98

14

ZNF29G29R

RREIIBTR _G47_2AP

1.020 ± 0.019

3.30E+06 ± 5.26E+05

-4343 ± 118

15.3

ZNF29G29R

RREIIBTR _C49U

1.070 ± 0.018

1.96E+06 ± 2.18E+05

-6071 ± 136

8.43

ZNF29G29R

RREIIBTR _C69U

0.976 ± 0.028

3.93E+06 ± 9.60E+05

-8560 ± 323

1.46

ZNF29G29R

RREIIBTR

Temperature

288 K

1.050 ± 0.024

1.51E+07 ±6.75E+06

-1884 ± 79

26.3

ZNF29G29R

RREIIBTR

Temperature

293 K

0.958 ± 0.016

1.76E+07 ± 3.95E+06

-3435 ± 68

21.4

ZNF29G29R

RREIIBTR

Temperature

303 K

1.080 ± 0.025

1.41E+07 ± 3.14E+06

-6604 ± 143

10.9

ZNF29G29R

RREIIBTR

Temperature

308 K

0.915 ± 0.022

7.92E+06 ±1.71E+06

-7705 ± 194

6.56

ZNF29G29R

RREIIBTR

pH

6.25

0.975 ± 0.043

2.90E+06 ± 6.98E+05

-7017 ± 410

6.03

ZNF29G29R

RREIIBTR

pH

8.22

0.931 ± 0.026

7.18E+06 ± 1.87E+06

-7076 ± 234

7.64

ZNF29G29R

RREIIBTR

Buffer, ACES

10mM

0.925 ± 0.044

1.19E+07 ± 5.80E+06

-6337 ± 473

13.8
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Protein

RNA

Changed

Changed

Condition

Values

n

Ka
M

-1

!H
cal mol

!S
-1

-1

cal mol K

ZNF29G29R

RREIIBTR

NaCl conc

50 mM

1.010 ± 0.018

3.00E+07 ±1.30E+07

-4581 ± 131

18.8

ZNF29G29R

RREIIBTR

NaCl conc

150 mM

0.987 ± 0.013

3.15E+06 ± 4.34E+05

-4219 ± 109

15.6

ZNF29

RREIIBTR

NaCl conc

50 mM

0.955 ± 0.023

8.29E+06 ± 2.41E+06

-5906 ± 194

11.8

ZNF29

RREIIBTR

NaCl conc

150 mM

0.947 ± 0.021

3.22E+06 ± 5.15E+05

-4261 ± 125

15.5

ZNF29G29R

RREIIBTR

Anion,NaBr

100 mM

0.988 ± 0.020

9.23E+06 ± 1.55E+06

-5576 ± 138

13.145

ZNF29G29R

RREIIBTR

Anion,NaF

100 mM

1.050 ± 0.026

3.76E+06 ± 7.69E+05

-7715 ± 253

4.21

ZNF29G29R

RREIIBTR

Sucrose

0.2 osm

0.920 ± 0.013

6.36E+06 ± 9.10E+05

-5732 ± 106

12

ZNF29G29R

RREIIBTR

Sucrose

0.6 osm

0.921 ± 0.018

4.02E+06 ± 6.23E+05

-6665 ± 176

7.86

ZNF29G29R

RREIIBTR

Sucrose

1.0 osm

0.921 ± 0.024

4.25E+06 ±8.81E+05

-6573 ± 225

8.28

-1

* The columns ”Changed Condition” and “Changed Values” refer to the changes or added components in the buffer.
The buffer components are: 10 mM Sodium phosphate,100 mM NaCl, 200 µM "-Mercaptoethanol.
The pH for all experiments were adjusted to be ~ 7 ± 0.02 units except in the changed pH experiments.
All experiments were performed at 298 K except in the changed temperature experiments.
The equations used to calculate the data in chapter 4 from the tables above are as follows:
!G = !H - T!S
!G = -RTln(Ka)
R = 1.987 kcal mol-1 K-1
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